https://curecurrent.com/trials/oleocanthal-rich-olive-oil-acute-effects-on-hyperglycemia-and-platelet-activation-in-t2dm-17001https://curecurrent.com/trials/randomised-open-label-study-of-insulin-degludec-versus-insulin-glargine-u100-in-ramadan-17002https://curecurrent.com/trials/an-international-survey-of-the-occurrence-of-cardiovascular-disease-among-patients-with-type-2-diabetes-17003https://curecurrent.com/trials/improving-mental-health-through-integration-with-primary-care-in-rural-karnataka-17004https://curecurrent.com/trials/rct-for-evaluation-of-insulin-administration-while-using-the-iport-system-17005https://curecurrent.com/trials/less-infections-for-the-diabetic-foot-17006https://curecurrent.com/trials/hypoglycemia-requiring-emergency-services-intervention-patient-characteristics-outcome-and-cardiovascular-risk-profile-17007https://curecurrent.com/trials/gut-and-oral-microbiome-of-gdm-patients-during-pregnancy-17008https://curecurrent.com/trials/a-comparative-study-of-ly900014-with-insulin-lispro-humalog-in-participants-with-type-2-diabetes-mellitus-t2dm-17009https://curecurrent.com/trials/relationship-between-chronic-renal-disease-and-risk-stratification-for-chronic-ulcer-on-the-on-the-diabetic-foot-17010https://curecurrent.com/trials/assessment-of-pcr-multiplex-tests-as-a-tool-to-obtain-a-quicker-diagnosis-of-bacteria-responsible-for-foot-osteomyelitis-17011https://curecurrent.com/trials/the-santa-cruz-diabetic-retinopathy-utilizing-artificial-intelligence-study-17012https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-tolerability-of-medi0382-in-overweight-and-obese-participants-with-type-2-diabetes-me-17013https://curecurrent.com/trials/observational-study-of-effectiveness-and-tolerability-of-gliclazide-mr-60mg-in-diabetic-patients-fasting-during-ramadan-17014https://curecurrent.com/trials/estrogen-diabetes-and-endothelial-function-17015https://curecurrent.com/trials/determining-serum-and-urinary-levels-of-mirna-192-and-mirna-25-in-patients-with-and-without-type-2-diabetes-17016https://curecurrent.com/trials/evaluation-of-the-management-of-diabetic-foot-ulcers-by-telemedicine-on-the-number-of-hospital-days-in-diabetic-patients-17017https://curecurrent.com/trials/social-prescription-and-lifestyles-modification-to-reduce-glycemia-in-people-with-prediabetes-predibal-17018https://curecurrent.com/trials/how-does-the-spirituality-of-patients-with-type-2-diabetes-influence-their-self-management-17019https://curecurrent.com/trials/normoalbuminuric-chronic-kidney-disease-in-type-2-diabetes-17020https://curecurrent.com/trials/digital-assisted-monitoring-for-diabetes-i-17021https://curecurrent.com/trials/study-of-exenatide-once-weekly-suspension-in-chinese-patients-with-type-2-diabetes-mellitus-17022https://curecurrent.com/trials/neuromuscular-adaptations-to-exercise-in-patients-with-type-2-diabetes-mellitus-17023https://curecurrent.com/trials/effect-of-reflexology-on-diabetic-foot-and-glycemic-control-in-elderly-diabetic-individuals-17024https://curecurrent.com/trials/covid-19-and-diabetes-in-west-of-algeria-17025https://curecurrent.com/trials/l-arginine-and-asymmetric-dimethylarginine-adma-and-lifestyle-protocols-17026https://curecurrent.com/trials/safety-and-efficacy-study-of-islets-xenotransplantation-17027https://curecurrent.com/trials/transfoveal-micropulse-laser-for-center-involving-diabetic-macular-edema-17028https://curecurrent.com/trials/glucose-metabolism-after-partial-pancreatectomy-17029https://curecurrent.com/trials/safety-and-efficacy-of-gpoem-in-the-treatment-of-gastroparesis-17030https://curecurrent.com/trials/sarcopenia-and-diabetes-mellitus-17031https://curecurrent.com/trials/a-single-escalating-dose-study-of-ertugliflozin-pf-04971729-mk-8835-under-fed-and-fasted-conditons-in-healthy-volunteers-17032https://curecurrent.com/trials/effect-of-group-patient-education-on-glycemic-control-among-people-living-with-type-2-diabetes-in-vietnam-17033https://curecurrent.com/trials/effect-of-cinnamomum-zeylanicum-on-glycemic-levels-of-adult-patients-with-type-2-diabetes-17034https://curecurrent.com/trials/electronic-medical-records-and-genomics-emerge-phase-iii-17035https://curecurrent.com/trials/effect-of-meal-timing-in-t2d-on-hepatocytes-srit1-and-clock-genes-17036https://curecurrent.com/trials/effect-of-adding-metformin-to-insulin-therapy-on-pregnancy-outcomes-in-women-with-uncontrolled-type-i-diabetes-17037https://curecurrent.com/trials/safety-and-efficacy-of-artificial-pancreas-with-and-without-a-meal-detection-module-on-glycemic-control-in-adolescents-w-17038https://curecurrent.com/trials/a-study-of-ly900014-in-participants-with-type-2-diabetes-mellitus-17039https://curecurrent.com/trials/evaluation-of-2-diets-with-different-starch-digestibility-profiles-on-daily-glycemic-profile-in-t2d-patients-17040https://curecurrent.com/trials/stimulation-tcpo2-test-in-the-pad-diagnosis-in-diabetic-foot-17041https://curecurrent.com/trials/effect-of-mediterranean-diet-on-the-microbiome-of-individuals-with-type-2-diabetes-17042https://curecurrent.com/trials/mapping-genes-for-type-2-non-insulin-dependent-diabetes-mellitus-17043https://curecurrent.com/trials/hypotonic-hyponatremia-criteria-for-the-correct-classification-of-its-etiology-and-of-patient-volume-status-17044https://curecurrent.com/trials/fibre-grain-herb-trial-in-type-2-diabetes-17045https://curecurrent.com/trials/influence-of-circadian-clock-on-hormonal-metabolic-neurocognitive-markers-in-adolescents-with-and-without-diabetes-17046https://curecurrent.com/trials/exploring-the-comorbidity-between-mental-disorders-and-general-medical-conditions-17047https://curecurrent.com/trials/gut-microbiota-scfas-and-glucolipid-metabolism-in-pregnant-women-with-abnormal-fetal-size-and-their-newborns-17048https://curecurrent.com/trials/gdm-patients-and-serum-amyloid-a-and-interleukin-1-il-1-receptor-antagonist-17049https://curecurrent.com/trials/remission-evaluation-of-metabolic-interventions-in-type-2-diabetes-remit-pilot-trial-17050https://curecurrent.com/trials/neuropeptide-therapy-of-recent-onset-type-1-diabetes-17051https://curecurrent.com/trials/a-study-to-investigate-the-bioequivalence-test-of-da-1229-01-a-at-fed-state-17052https://curecurrent.com/trials/a-study-to-investigate-the-bioequivalence-test-of-da-1229-01-a-at-fasting-state-17053https://curecurrent.com/trials/flash-glucose-measure-system-and-continuous-subcutaneous-insulin-infusion-therapy-in-poorly-controlled-diabetes-type-1-p-17054https://curecurrent.com/trials/effect-of-high-caloric-diet-on-brain-insulin-sensitivity-and-inflammation-17055https://curecurrent.com/trials/the-effect-of-fasting-on-serum-osmolarity-in-diabetic-patients-17056https://curecurrent.com/trials/association-of-carbamylated-hdl-and-cad-in-t2dm-patients-17057https://curecurrent.com/trials/mediges-study-metformine-use-in-gestational-diabetes-17058https://curecurrent.com/trials/efficacy-and-safety-of-shr3824-in-combination-with-metformin-in-subjects-with-type-2-diabetes-17059https://curecurrent.com/trials/comparison-of-insulin-tregopil-in-105-with-insulin-aspart-in-type-2-diabetes-mellitus-patients-17060https://curecurrent.com/trials/effects-of-linagliptin-on-endothelial-function-17061https://curecurrent.com/trials/web-based-approach-in-nutrition-and-diabetes-17062https://curecurrent.com/trials/perceived-stress-and-negative-thoughts-with-biomarkers-in-people-with-type-2-diabetes-mellitus-and-healthy-subjects-17063https://curecurrent.com/trials/joint-management-of-dm2-and-pulmonary-tb-in-orizaba-veracruz-17064https://curecurrent.com/trials/dipeptidyl-peptidase-4-inhibition-in-psoriasis-patients-with-diabetes-dip-a-randomized-clinical-trial-17065https://curecurrent.com/trials/optimizing-statin-tratment-in-people-living-with-diabetes-17066https://curecurrent.com/trials/effect-of-vitrectomy-on-the-evolution-of-refractory-diabetic-macular-edema-17067https://curecurrent.com/trials/prognostic-factors-keeping-track-for-covid-19-pneumonia-17068https://curecurrent.com/trials/a-comparative-study-of-ly900014-with-insulin-lispro-humalog-in-participants-with-type-1-diabetes-mellitus-17069https://curecurrent.com/trials/antrum-size-glucagon-like-peptide-1-levels-and-glycemic-control-after-sleeve-gastrectomy-in-morbid-obese-diabetic-adoles-17070https://curecurrent.com/trials/safety-and-efficacy-study-of-tesofensine-metoprolol-treatment-in-subjects-with-type-2-diabetes-mellitus-17071https://curecurrent.com/trials/sitagliptin-therapy-and-kinetics-of-inflammatory-markers-17072https://curecurrent.com/trials/incidence-of-diabetes-and-metabolic-disorders-after-tips-in-cirrhotic-patients-17073https://curecurrent.com/trials/stevia-rebaudiana-bertoni-on-levels-of-gcf-glucose-and-bio-markers-in-diabetics-17074https://curecurrent.com/trials/carbohydrate-and-insulin-requirements-during-prolonged-fasted-exercise-17075https://curecurrent.com/trials/relation-between-plasma-apelin-level-and-diabetic-nephropathy-in-type-2-diabetes-patients-17076https://curecurrent.com/trials/fish-or-nuts-dietary-effects-on-cardiometabolic-risk-factors-and-persistent-organic-pollutants-17077https://curecurrent.com/trials/new-biomarkers-for-diagnosis-and-follow-up-of-patients-with-lrba-or-ctla4-deficiencies-17078https://curecurrent.com/trials/evaluation-of-compression-therapy-in-patients-with-mild-to-moderate-pad-or-diabetes-mellitus-17079https://curecurrent.com/trials/measurement-algorithm-control-and-optimization-with-subsequent-performance-evaluation-of-sanmina-non-invasive-biosensors-17080https://curecurrent.com/trials/anti-inflammatory-effect-of-curcumin-homotaurine-vitamin-d3-on-human-vitreous-in-patients-with-diabetic-retinopathy-17081https://curecurrent.com/trials/injection-of-subcutaneous-glucose-10-in-small-shots-is-effective-in-the-treatment-of-diabetic-neuropathic-pain-17082https://curecurrent.com/trials/the-impact-of-lixisenatide-on-postprandial-glucose-tolerance-in-pancreatectomised-subjects-17083https://curecurrent.com/trials/cell-function-and-insulin-sensitivity-in-patients-with-cystic-fibrosis-17084https://curecurrent.com/trials/gaba-and-beta-cell-regeneration-17085https://curecurrent.com/trials/colchicine-has-anti-diabetic-effect-17086https://curecurrent.com/trials/clinical-and-echocardiographic-management-of-patients-with-heart-failure-and-diabetes-scodiac-follow-up-study-17087https://curecurrent.com/trials/high-vs-low-dose-vitamin-d-in-patients-with-diabetic-peripheral-neuropathy-17088https://curecurrent.com/trials/vascular-lifestyle-intervention-and-screening-in-pharmacy-17089https://curecurrent.com/trials/dose-modification-requirement-for-trelagliptin-in-egyptian-population-17090https://curecurrent.com/trials/characterization-of-metabolic-and-brain-effects-of-rising-glucagon-during-an-oral-glucose-challenge-17091https://curecurrent.com/trials/treatment-study-of-negative-pressure-wound-therapy-for-diabetic-foot-wounds-17092https://curecurrent.com/trials/vasopressin-injection-technique-to-preserve-ovarian-reserve-in-surgery-for-unilateral-ovarian-endometriomas-17093https://curecurrent.com/trials/novel-intervention-linking-public-housing-with-primary-care-to-prevent-diabetes-17094https://curecurrent.com/trials/a-randomized-controlled-trial-of-mecobalamin-injection-and-tablet-treatment-efficacy-on-mild-to-moderate-diabetic-periph-17095https://curecurrent.com/trials/short-duration-hyperbaric-oxygen-therapy-to-improve-hba1c-leukocyte-and-serum-creatinine-17096https://curecurrent.com/trials/effect-of-manual-therapy-on-tibiotarsal-joint-mobility-in-diabetic-individuals-17097https://curecurrent.com/trials/a-study-of-ly900014-in-japanese-participants-with-type-1-diabetes-mellitus-17098https://curecurrent.com/trials/nutritional-ketosis-in-heart-failure-17099https://curecurrent.com/trials/a-study-of-ly900014-administered-in-participants-with-type-1-diabetes-using-an-insulin-pump-17100https://curecurrent.com/trials/investigating-the-acute-effect-of-alternative-forms-of-physical-activity-in-a-multi-ethnic-population-17101https://curecurrent.com/trials/a-comparative-study-of-ly900014-to-insulin-lispro-humalog-in-healthy-participants-17102https://curecurrent.com/trials/protocol-of-metabolic-and-cryptogenic-liver-disease-registry-for-integration-of-omic-studies-17103https://curecurrent.com/trials/a-meal-test-study-of-ly900014-in-participants-with-type-1-diabetes-mellitus-17104https://curecurrent.com/trials/nutrition-product-combine-with-continuous-glucose-monitoring-in-gestational-diabetes-mellitus-patients-17105https://curecurrent.com/trials/a-study-of-ly900014-formulation-at-different-injection-sites-in-healthy-participants-17106https://curecurrent.com/trials/a-cold-physical-treatment-to-manage-insulin-resistance-17107https://curecurrent.com/trials/a-study-of-ly900014-in-elderly-and-younger-adult-participants-with-type-1-diabetes-mellitus-17108https://curecurrent.com/trials/the-impact-of-activity-promoting-video-games-on-glycemic-control-in-gestational-diabetes-mellitus-17109https://curecurrent.com/trials/effect-of-empagliflozin-versus-placebo-on-brain-insulin-sensitivity-in-patients-with-prediabetes-17110https://curecurrent.com/trials/the-use-of-the-cpr-to-predict-adverse-outcomes-in-gdm-pregnancies-17111https://curecurrent.com/trials/evaluation-of-novartis-access-a-non-communicable-disease-ncd-access-initiative-17112https://curecurrent.com/trials/foot-intervention-study-utilizing-commercially-available-infrared-thermometers-with-individuals-with-diabetes-17113https://curecurrent.com/trials/fecal-microbiota-transplantation-as-a-therapeutic-strategy-in-the-progression-of-chronic-kidney-disease-17114https://curecurrent.com/trials/nutritional-metabolic-and-respiratory-status-in-cystic-fibrosis-17115https://curecurrent.com/trials/carefully-selected-and-easily-accessible-at-no-charge-medications-17116https://curecurrent.com/trials/is-real-time-cgm-superior-to-flash-glucose-monitoring-17117https://curecurrent.com/trials/prospective-interventional-study-on-reversibility-of-type-2-diabetes-mellitus-with-hypocaloric-diet-17118https://curecurrent.com/trials/gad-alum-diamyd-administered-into-lymph-nodes-in-combination-with-vitamin-d-in-type-1-diabetes-diagnode-1-17119https://curecurrent.com/trials/a-clinical-study-to-investigate-the-effects-of-dapagliflozin-on-heart-work-heart-nutrient-uptake-and-heart-muscle-effici-17120https://curecurrent.com/trials/effect-of-glucocorticoid-on-exogenous-insulin-antibody-syndrome-17121https://curecurrent.com/trials/ramadan-flash-glucose-monitoring-study-17122https://curecurrent.com/trials/effect-of-real-time-continuous-glucose-monitoring-system-in-overweight-or-obese-adults-with-prediabetes-17123https://curecurrent.com/trials/predictors-of-coronary-revascularization-outcomes-in-type-2-diabetic-patients-with-acute-coronary-syndrome-17124https://curecurrent.com/trials/personalized-nutrition-for-pre-diabetes-17125https://curecurrent.com/trials/effectiveness-of-motivational-interviewing-on-improving-care-for-patients-with-type-2-diabetes-in-china-17126https://curecurrent.com/trials/a-study-to-evaluate-safety-and-effectiveness-in-patients-of-all-age-groups-excluding-less-than-12-months-old-infants-wit-17127https://curecurrent.com/trials/safety-tolerability-pharmacodynamics-and-pharmacokinetics-of-jy09-17128https://curecurrent.com/trials/a-novel-carbohydrate-counting-smartphone-app-for-youth-with-type-1-diabetes-17129https://curecurrent.com/trials/effect-of-sodium-glucose-co-transporter-2-inhibitor-sglt2-on-proteinuria-in-diabetic-patients-17130https://curecurrent.com/trials/acute-effect-of-hp-211-axulin-on-blood-glucose-and-serum-insulin-responses-in-healthy-lean-and-overweight-humans-17131https://curecurrent.com/trials/diabetes-care-programme-for-type-2-diabetes-mellitus-in-primary-care-setting-17132https://curecurrent.com/trials/microwave-radiometry-thermometry-for-the-diagnosis-of-critical-limb-ischemia-in-diabetic-patients-17133https://curecurrent.com/trials/efficacy-and-safety-of-gp40081-ompared-to-novomix-30-flexpen-in-type-2-diabetes-mellitus-patients-17134https://curecurrent.com/trials/study-of-impact-of-art-therapy-sessions-given-to-family-caregivers-of-children-with-type-1-diabetes-17135https://curecurrent.com/trials/effectiveness-of-foot-exercise-people-with-type-2-diabetes-17136https://curecurrent.com/trials/effect-of-premeal-protein-bar-on-glycemic-control-in-patients-with-type-2-diabetes-17137https://curecurrent.com/trials/bioequivalence-study-for-acarbose-metformin-fdc-17138https://curecurrent.com/trials/different-dietary-interventions-and-glycemia-in-t1dm-17139https://curecurrent.com/trials/a-low-dose-radiation-and-contrast-agent-exposure-protocol-for-coronary-cta-in-diabetic-patients-17140https://curecurrent.com/trials/a-study-to-look-at-the-effect-medi0382-has-on-blood-sugar-in-people-with-type-2-diabetes-and-kidney-problems-and-also-to-17141https://curecurrent.com/trials/effect-of-standardized-hibiscus-sabdariffa-tea-in-seemingly-healthy-human-volunteers-17142https://curecurrent.com/trials/high-intensity-interval-training-training-protocols-on-cardiorespiratory-parameters-in-patients-with-type-2-diabetes-17143https://curecurrent.com/trials/the-effects-of-aerobic-exercises-on-exercise-capacity-in-type-2-diabetes-mellitus-17144https://curecurrent.com/trials/measurement-algorithm-control-optimization-and-performance-evaluation-of-the-vital-usa-glucosedetect-17145https://curecurrent.com/trials/screening-patients-with-diabetes-mellitus-for-the-presence-of-skin-disorder-of-scleredema-17146https://curecurrent.com/trials/study-in-diabetes-mellitus-patients-without-prior-myocardial-infarction-or-stroke-undergoing-elective-percutaneous-coron-17147https://curecurrent.com/trials/the-role-of-glucagon-in-the-effects-of-dipeptidyl-peptidase-4-inhibitors-and-sodium-glucose-co-transporter-2-inhibitors-17148https://curecurrent.com/trials/perioperative-continuous-glucose-monitoring-in-patients-undergoing-an-abdominal-surgery-17149https://curecurrent.com/trials/continuos-subcutaneous-insulin-infusion-in-italy-17150https://curecurrent.com/trials/effect-of-cilostazol-on-carotid-atherosclerosis-estimated-by-3d-ultrasound-in-patients-with-type-2-diabetes-17151https://curecurrent.com/trials/nutrition-education-intervention-for-adults-with-type-2-diabetes-17152https://curecurrent.com/trials/medium-chain-triglycerides-and-aerobic-exercise-on-ketone-production-in-women-with-or-without-prediabetes-17153https://curecurrent.com/trials/evaluating-plantar-foot-pressure-in-a-novel-diabetic-offloading-device-17154https://curecurrent.com/trials/the-metabolic-impact-of-bariatric-surgery-compared-to-best-diabetic-care-on-manitoba-s-urban-indigenous-population-17155https://curecurrent.com/trials/effects-of-hypoglycemic-drugs-on-testosterone-levels-in-type-2-diabetes-patients-17156https://curecurrent.com/trials/study-of-combination-therapy-of-gliclazide-mr-and-basal-insulin-versus-insulin-monotherapy-to-treat-type-2-diabetes-17157https://curecurrent.com/trials/glycemic-profile-by-cgms-in-diabetic-patients-after-bariatric-surgery-17158https://curecurrent.com/trials/type-2-diabetes-mellitus-patients-characteristics-and-management-by-general-practitioners-and-endocrinologists-17159https://curecurrent.com/trials/the-role-of-the-thymus-in-type-i-diabetes-17160https://curecurrent.com/trials/immunogenicity-study-of-insulin-glargine-ezelin-vs-lantus-in-type-2-diabetes-mellitus-patients-17161https://curecurrent.com/trials/the-potential-of-dapagliflozin-plus-exenatide-in-obese-insulin-resistant-patients-17162https://curecurrent.com/trials/effectiveness-of-pharmacotherapy-follow-up-care-in-outpatients-with-type-2-diabetes-mellitus-17163https://curecurrent.com/trials/diabetic-patients-needs-in-therapeutic-education-about-work-te-diw-therapeutic-education-of-diabetic-working-people-17164https://curecurrent.com/trials/flat-and-circadian-insulin-infusion-rates-in-continuous-subcutaneous-insulin-infusion-17165https://curecurrent.com/trials/characterization-of-local-and-systemic-bone-markers-in-diabetes-patients-with-charcot-osteoarthropathy-17166https://curecurrent.com/trials/bariatric-surgery-for-the-treatment-of-type-2-diabetes-clinical-effects-and-underlying-mechanisms-17167https://curecurrent.com/trials/effects-of-obesity-treatments-on-food-preferences-and-metabolism-17168https://curecurrent.com/trials/prospective-randomized-clinical-trial-assessing-the-short-term-clinical-impact-of-continuous-vs-flash-glucose-monitoring-17169https://curecurrent.com/trials/characterization-of-the-charcot-foot-17170https://curecurrent.com/trials/early-screening-of-gestational-diabetes-mellitus-and-prospective-cohort-study-of-postpartum-follow-up-17171https://curecurrent.com/trials/efficacy-of-laser-debridement-on-pain-and-bacterial-load-in-chronic-wounds-17172https://curecurrent.com/trials/saxagliptin-and-cardiac-structure-and-function-17173https://curecurrent.com/trials/freestyle-libre-use-in-real-life-efficacy-and-acceptance-17174https://curecurrent.com/trials/comparison-of-safety-and-efficacy-of-qs-m-needle-free-injector-and-insulin-pen-in-controlling-t2dm-patient-s-glucose-17175https://curecurrent.com/trials/a-clinical-study-to-access-the-pharmacokinetics-of-hms5552-in-renal-impaired-subjects-and-healthy-volunteers-17176https://curecurrent.com/trials/dietary-intervention-gestational-weight-gain-and-gestational-diabetes-17177https://curecurrent.com/trials/eversense-and-dexcom-g5-efficacy-and-accuracy-in-type-1-diabetic-patients-17178https://curecurrent.com/trials/effect-of-exenatide-lar-or-dulaglutide-on-the-variability-of-24-hour-heart-rate-and-blood-pressure-in-type-2-diabetes-17179https://curecurrent.com/trials/qol-and-stress-in-parents-of-children-with-developmental-disabilities-and-chronic-disease-17180https://curecurrent.com/trials/delineation-of-the-role-of-glucagon-like-peptide-1-signalling-in-relation-to-increased-carbohydrate-content-in-the-dista-17181https://curecurrent.com/trials/community-web-health-portal-for-diabetes-prevention-17182https://curecurrent.com/trials/a-double-blind-randomised-placebo-controlled-trial-to-assess-the-role-of-iron-repletion-in-glucose-homeostasis-17183https://curecurrent.com/trials/effectiveness-of-an-intervention-in-improving-medication-adherence-among-malay-patients-with-underlying-type-2-diabetes-17184https://curecurrent.com/trials/study-of-the-effect-of-diabetes-on-the-incidence-and-the-extent-of-coronary-artery-disease-17185https://curecurrent.com/trials/clinical-study-to-evaluate-the-pharmacokinetic-profiles-and-safety-of-ckd-389-17186https://curecurrent.com/trials/family-factors-in-young-people-with-diabetes-a-qualitative-study-17187https://curecurrent.com/trials/rapid-eye-movement-related-osa-in-diabetic-versus-non-diabetic-patients-treated-with-pci-17188https://curecurrent.com/trials/complement-study-a-first-in-human-study-of-metabolic-neuromodulation-therapy-17189https://curecurrent.com/trials/home-based-exercise-for-patients-with-type-2-diabetes-17190https://curecurrent.com/trials/linagliptin-add-on-to-insulin-background-therapy-17191https://curecurrent.com/trials/phototherapy-in-dm-amputation-ulcers-17192https://curecurrent.com/trials/screening-of-microalbuminuria-using-a-semi-quantitative-uacr-test-17193https://curecurrent.com/trials/supplementation-of-eriocitrin-in-intestinal-microbiota-17194https://curecurrent.com/trials/periodontal-treatment-and-metabolic-control-in-type-2-diabetic-patients-17195https://curecurrent.com/trials/promoting-physical-activity-in-patients-with-type-2-diabetes-diafit-17196https://curecurrent.com/trials/myoinositol-supplementation-insulin-resistance-and-fetal-sonographic-parameters-in-gestational-diabetes-diet-treated-17197https://curecurrent.com/trials/blood-glucose-cognition-and-wellbeing-work-17198https://curecurrent.com/trials/progression-of-diabetic-retinopathy-identification-of-signs-and-surrogate-outcomes-17199https://curecurrent.com/trials/a-targeted-and-tailored-pharmacist-intervention-to-improve-adherence-to-antihypertensive-drugs-among-diabetes-patients-17200https://curecurrent.com/trials/improving-diabetes-outcomes-for-people-with-severe-mental-illness-smi-17201https://curecurrent.com/trials/the-effect-of-random-vibrations-on-perception-and-balance-17202https://curecurrent.com/trials/effects-of-stress-on-glucose-tolerance-during-pregnancy-17203https://curecurrent.com/trials/effect-of-dapagliflozin-on-iah-in-t1dm-17204https://curecurrent.com/trials/pharmacist-counseling-on-the-health-related-quality-of-life-of-patients-with-type-2-diabetes-mellitus-17205https://curecurrent.com/trials/effects-of-exercise-on-metabolic-parameters-in-patients-with-type-2-diabetes-mellitus-17206https://curecurrent.com/trials/effect-of-probiotics-vivomixx-on-weight-microbiota-and-glucose-tolerance-in-obese-pregnant-women-and-their-newborn-17207https://curecurrent.com/trials/the-effect-of-platelet-rich-plasma-fibrin-glue-in-combination-with-vitamin-e-and-c-for-treatment-of-non-healing-diabetic-17208https://curecurrent.com/trials/metabolic-syndrome-and-non-alcoholic-fatty-liver-during-pregnancy-17209https://curecurrent.com/trials/effects-of-a-small-protein-and-lipid-preload-on-glucose-tolerance-in-subjects-with-impaired-glucose-homeostasis-17210https://curecurrent.com/trials/abnormal-blood-sugar-tests-in-diabetic-patients-during-colonoscopy-preparation-17211https://curecurrent.com/trials/a-collaborative-approach-in-diabetes-foot-education-a-pragmatic-randomised-control-trial-17212https://curecurrent.com/trials/early-glycaemic-control-in-type-2-diabetes-patients-after-bariatric-surgery-ecodabs-17213https://curecurrent.com/trials/a-trial-comparing-insulin-degludec-liraglutide-and-insulin-degludec-in-combination-with-metformin-in-chinese-subjects-wi-17214https://curecurrent.com/trials/effect-of-blood-flow-restricted-aerobic-exercise-in-type-2-diabetes-mellitus-17215https://curecurrent.com/trials/a-research-study-looking-at-how-faster-aspart-injected-in-double-concentration-works-in-the-body-of-people-with-type-1-d-17216https://curecurrent.com/trials/the-effect-of-early-life-risk-factors-on-the-etiology-of-diabetes-in-children-a-birth-cohort-17217https://curecurrent.com/trials/a-study-of-basal-insulin-analog-and-insulin-analog-mid-mixture-in-chinese-participants-with-type-2-diabetes-mellitus-17218https://curecurrent.com/trials/study-on-how-fiasp-can-influence-blood-sugar-levels-of-type1-diabetic-patients-in-their-daily-lives-with-the-help-of-the-17219https://curecurrent.com/trials/metformin-plus-insulin-on-non-obese-autoimmune-diabetes-17220https://curecurrent.com/trials/seoul-national-university-pituitary-disease-cohort-study-17221https://curecurrent.com/trials/liraglutide-as-additional-treatment-to-insulin-in-patients-with-autoimmune-diabetes-mellitus-17222https://curecurrent.com/trials/cgm-in-utah-valley-17223https://curecurrent.com/trials/current-state-of-impaired-awareness-of-hypoglycaemia-in-people-with-type-1-diabetes-17224https://curecurrent.com/trials/panretinal-photo-stimulation-in-proliferative-diabetic-retinopathy-17225https://curecurrent.com/trials/evidence-based-nutrition-practice-guidelines-of-toolkit-and-preliminary-outcomes-17226https://curecurrent.com/trials/forxiga-dapagliflozin-regulatory-postmarketing-surveillance-17227https://curecurrent.com/trials/hypoglycemia-low-blood-sugar-and-the-heart-17228https://curecurrent.com/trials/optimizing-care-of-patients-via-telehealth-in-monitoring-and-augmenting-their-control-of-diabetes-mellitus-17229https://curecurrent.com/trials/light-emitting-diode-in-diabetic-subjects-17230https://curecurrent.com/trials/study-of-tq-f3083-capsules-in-subjects-with-type-2-diabetes-mellitus-17231https://curecurrent.com/trials/molecular-mechanisms-of-raspberries-effect-on-insulin-resistance-and-inflammation-17232https://curecurrent.com/trials/examining-the-role-of-family-support-in-bariatric-surgery-patients-17233https://curecurrent.com/trials/cardiovascular-outcomes-sglt-2-inhibitors-versus-glp-1-receptor-agonists-17234https://curecurrent.com/trials/value-of-sglt2-inhibitor-dapagliflozin-as-an-added-therapy-in-diabetic-patients-with-heart-failure-with-reduced-ejection-17235https://curecurrent.com/trials/comparative-effectiveness-of-dapagliflozin-versus-dpp-4-inhibitors-17236https://curecurrent.com/trials/sophia-step-study-a-behaviour-change-program-on-physical-activity-in-persons-with-pre-and-type-2-diabetes-17237https://curecurrent.com/trials/culturally-adapted-diabetes-prevention-lifestyle-intervention-for-latinos-e-lite-latinos-17238https://curecurrent.com/trials/a-multi-center-12-week-study-of-hms5552-in-t2dm-17239https://curecurrent.com/trials/oat-beta-glucan-as-a-supplement-in-chilean-type-2-diabetics-17240https://curecurrent.com/trials/effect-of-exenatide-on-24h-uaer-in-patients-with-diabetic-nephropathy-17241https://curecurrent.com/trials/impact-of-meal-composition-and-alcohol-consumption-on-postprandial-glycemic-control-in-subjects-with-type-1-diabetes-17242https://curecurrent.com/trials/diabeloop-for-kids-17243https://curecurrent.com/trials/nesfatin-1-level-in-patients-with-type-2-diabetes-insulin-resistance-and-obesity-17244https://curecurrent.com/trials/low-energy-shockwave-therapy-le-swt-a-novel-treatment-for-chronic-kidney-disease-17245https://curecurrent.com/trials/the-peer-led-self-management-program-17246https://curecurrent.com/trials/metabolic-surgery-for-steato-hepatitis-17247https://curecurrent.com/trials/effect-of-camel-milk-with-probiotic-on-type-2-diabetes-mellitus-17248https://curecurrent.com/trials/effect-of-anti-diabetic-drugs-on-glycemic-variability-17249https://curecurrent.com/trials/metformin-in-older-adults-with-type-2-diabetes-amemet-17250https://curecurrent.com/trials/an-ascending-dose-single-multiple-dosing-food-effect-clinical-trial-to-evaluate-pharmacokinetics-safety-and-tolerability-17251https://curecurrent.com/trials/metformin-in-women-with-type-2-diabetes-in-pregnancy-trial-17252https://curecurrent.com/trials/effects-of-a-portfolio-diet-on-nafld-in-type-2-diabetic-patients-17253https://curecurrent.com/trials/sodium-glucose-co-transporter-2-inhibitors-effects-in-failing-heart-patients-17254https://curecurrent.com/trials/improving-outcomes-using-collaborative-group-clinics-to-empower-older-patients-17255https://curecurrent.com/trials/assessing-the-efficacy-of-anti-staphylococcal-phages-in-the-management-of-infected-foot-ulcers-in-diabetes-17256https://curecurrent.com/trials/development-and-implementation-of-ramadan-fasting-algorithm-for-singaporeans-with-type-2-diabetes-17257https://curecurrent.com/trials/impact-evaluation-of-a-mobile-health-app-to-improve-self-control-and-health-outcomes-of-patients-with-type-2-diabetes-me-17258https://curecurrent.com/trials/a-pilot-study-of-the-woundwand-debridement-device-on-infection-prevention-17259https://curecurrent.com/trials/stem-cells-from-human-exfoliated-teeth-in-treatment-of-type-2-diabetes-17260https://curecurrent.com/trials/clinical-evaluation-of-lifescan-blood-glucose-monitoring-systems-17261https://curecurrent.com/trials/response-of-gut-microbiota-in-type-2-diabetes-to-hypoglycemic-agents-17262https://curecurrent.com/trials/relaxation-and-meditation-techniques-on-pain-fatigue-and-quality-of-life-17263https://curecurrent.com/trials/perioperative-continuation-of-metformin-therapy-in-patients-with-typ-2-diabetes-mellitus-undergoing-non-cardiac-surgery-17264https://curecurrent.com/trials/positive-predictive-value-of-the-moleculight-i-x-imaging-device-to-predict-the-presence-of-bacteria-in-chronic-wounds-17265https://curecurrent.com/trials/enhancing-the-vagal-tone-in-prediabetes-individuals-17266https://curecurrent.com/trials/18f-fdopa-pet-ct-imaging-in-patients-undergoing-metabolic-surgery-17267https://curecurrent.com/trials/using-calcium-dobesilate-to-treat-chinese-patients-with-mild-to-moderate-non-proliferative-diabetic-retinopathy-17268https://curecurrent.com/trials/meta-analysis-of-low-calorie-sweetened-beverages-and-cardiometabolic-outcomes-17269https://curecurrent.com/trials/forxiga-tablets-specific-clinical-experience-investigation-for-long-term-use-17270https://curecurrent.com/trials/bariatric-surgeries-and-glucose-homeostasis-during-a-mixed-meal-test-17271https://curecurrent.com/trials/could-ketoanalogue-supplemented-low-protein-diet-defer-dialysis-in-advanced-diabetic-kidney-disease-k-ddd-17272https://curecurrent.com/trials/passive-training-as-a-treatment-for-diabetic-foot-ulcers-17273https://curecurrent.com/trials/study-of-sulphonylurea-synergy-with-incretins-17274https://curecurrent.com/trials/canadian-real-world-outcomes-of-omnipod-initiation-in-people-with-t1d-17275https://curecurrent.com/trials/glycemic-control-and-endothelial-function-in-patients-with-type-2-diabetes-17276https://curecurrent.com/trials/real-world-health-outcomes-in-canadian-patients-using-semaglutide-17277https://curecurrent.com/trials/relationship-of-central-blood-pressure-and-pulse-wave-velocity-with-target-organ-damage-17278https://curecurrent.com/trials/blood-pressure-and-subclinical-organ-damage-17279https://curecurrent.com/trials/effect-of-dulaglutide-on-liver-fat-in-patients-with-type-2-diabetes-and-nonalcoholic-fatty-liver-disease-17280https://curecurrent.com/trials/the-correlation-between-hba1c-and-mean-blood-glucose-in-patients-with-diabetes-and-renal-failure-17281https://curecurrent.com/trials/coupling-of-neural-activity-and-retinal-blood-flow-in-diabetes-17282https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-dual-add-on-therapy-with-gemigliptin-50-mg-and-dapagliflozin-10-mg-added-17283https://curecurrent.com/trials/assessing-the-reliability-of-non-invasive-blood-glucose-monitoring-device-17284https://curecurrent.com/trials/person-centered-occupation-based-therapy-for-type-2-diabetes-17285https://curecurrent.com/trials/incretin-hormones-in-type-1-diabetes-mellitus-effect-of-metformin-treatment-17286https://curecurrent.com/trials/investigating-the-influence-of-oral-semaglutide-on-pharmacokinetics-of-metformin-and-digoxin-in-healthy-subjects-17287https://curecurrent.com/trials/comparison-between-dexcom-g5-mobile-continuous-glucose-monitoring-cgm-system-and-the-freestyle-libre-flash-glucose-monit-17288https://curecurrent.com/trials/a-trial-investigating-the-influence-of-oral-semaglutide-on-the-pharmacokinetics-of-lisinopril-and-warfarin-in-healthy-su-17289https://curecurrent.com/trials/effect-of-basal-bolus-closed-loop-co-administration-of-insulin-and-pramlintide-on-improving-the-glycemic-control-in-type-17290https://curecurrent.com/trials/qatar-diabetes-mobile-application-trial-17291https://curecurrent.com/trials/impact-of-empaglifozine-on-cardiac-ectopic-fat-17292https://curecurrent.com/trials/integration-of-education-based-application-and-care-coaching-model-in-management-of-type-2-diabetes-mellitus-patients-us-17293https://curecurrent.com/trials/an-alternative-approach-to-improve-hyperglycemia-among-type-2-diabetes-patients-17294https://curecurrent.com/trials/genetic-and-epigenetic-risk-of-t2d-in-the-uae-17295https://curecurrent.com/trials/difficulties-and-obstacles-to-the-integration-in-community-of-children-with-type-1-diabetes-before-primary-school-17296https://curecurrent.com/trials/pk-pd-biosimilarity-study-of-gan-lee-insulin-lispro-injection-vs-eu-and-us-humalog-in-healthy-males-17297https://curecurrent.com/trials/adipose-tissue-expandability-and-type-2-diabetes-17298https://curecurrent.com/trials/pk-pd-study-of-gan-lee-insulin-aspart-injection-vs-us-eu-novolog-novorapid-in-healthy-males-17299https://curecurrent.com/trials/effect-of-resistance-training-associated-with-whole-body-vibration-in-diabetes-17300https://curecurrent.com/trials/effect-of-metformin-on-exercise-induced-lipolysis-17301https://curecurrent.com/trials/safety-and-efficacy-of-herbal-tea-in-type-2-diabetics-17302https://curecurrent.com/trials/metabolic-control-before-and-after-supplementation-with-lactobacillus-reuteri-dsm-17938-in-type-2-diabetes-patients-17303https://curecurrent.com/trials/effects-of-pde-5-inhibition-on-postprandial-hyperglycemia-in-type-2-diabetes-17304https://curecurrent.com/trials/precision-nutrition-counseling-in-type-2-diabetes-patients-17305https://curecurrent.com/trials/efficacy-safety-and-tolerability-study-of-sotagliflozin-as-adjunct-therapy-in-adult-patients-with-type-1-diabetes-mellit-17306https://curecurrent.com/trials/starter-kit-study-in-insulin-na-ve-patients-17307https://curecurrent.com/trials/the-lira-pump-trial-17308https://curecurrent.com/trials/new-patient-support-program-in-type-2-diabetes-17309https://curecurrent.com/trials/long-term-sulfonylurea-response-in-abcc8-neonatal-diabetes-suresponssur-17310https://curecurrent.com/trials/efficacy-and-safety-of-vildagliptin-versus-placebo-in-patients-with-type-2-diabetes-17311https://curecurrent.com/trials/skills-for-change-nutrition-education-program-for-emirati-adults-with-type-2-diabetes-17312https://curecurrent.com/trials/mobile-application-for-educating-diabetics-about-foot-care-17313https://curecurrent.com/trials/effects-on-insulin-resistance-with-tadalafil-in-type-2-diabetes-a-double-blind-placebo-controlled-crossover-study-17314https://curecurrent.com/trials/the-influence-of-psychobiological-adversity-to-children-and-adolescents-with-type-1-diabetes-17315https://curecurrent.com/trials/the-study-to-investigate-the-contribution-of-basal-and-postprandial-glucose-to-overall-hyperglycemia-in-t2dm-17316https://curecurrent.com/trials/dosage-reduction-and-acute-glycemic-complications-in-people-with-type-2-diabetes-who-fast-during-ramadan-17317https://curecurrent.com/trials/dapagliflozin-saxagliptin-in-a-basal-bolus-insulin-treatment-17318https://curecurrent.com/trials/prognostic-predictors-of-response-to-hypoglycemic-therapy-17319https://curecurrent.com/trials/near-infrared-photobiomodulation-treatment-for-diabetic-macular-oedema-17320https://curecurrent.com/trials/discovering-treatment-reality-of-type-2-diabetes-in-real-world-setting-in-japan-17321https://curecurrent.com/trials/musculoskeletal-changes-after-physiotherapeutic-intervention-in-podiatric-subjects-17322https://curecurrent.com/trials/probiotics-in-diabesity-a-pilot-study-17323https://curecurrent.com/trials/placental-assessment-in-diabetic-mothers-17324https://curecurrent.com/trials/effect-of-cassia-cinnamon-on-arterial-stiffness-parameters-in-patients-with-type-2-diabetes-mellitus-17325https://curecurrent.com/trials/epidemiology-and-intervention-of-obstructive-sleep-apnea-based-on-community-17326https://curecurrent.com/trials/clinical-trial-comparing-two-health-education-programs-for-obese-patients-hepo-trial-17327https://curecurrent.com/trials/effectiveness-of-scdm-in-patients-with-type-2-diabetes-17328https://curecurrent.com/trials/a-clinical-study-to-evaluate-the-pharmacokinetics-and-safety-of-ckd-396-17329https://curecurrent.com/trials/high-salt-intake-unrelated-to-obesity-in-diabetes-17330https://curecurrent.com/trials/autologous-peripheral-blood-mononuclear-cells-in-diabetic-foot-patients-with-no-option-critical-limb-ischemia-17331https://curecurrent.com/trials/15-minute-individual-consultation-to-improve-blood-glucose-control-in-pre-diabetes-17332https://curecurrent.com/trials/multicomponent-integrated-intervention-on-metabolic-control-and-quality-of-life-in-type-2-diabetes-diabempic-program-17333https://curecurrent.com/trials/additional-insulin-for-fat-and-protein-in-children-with-diabetes-study-17334https://curecurrent.com/trials/cardiometabolic-risk-in-children-with-type-1-diabetes-17335https://curecurrent.com/trials/short-term-effects-of-a-hibiscus-sabdariffa-and-stevia-rebaudiana-drink-on-cardiac-relaxation-and-urinary-albumin-excret-17336https://curecurrent.com/trials/orchestra-pregnancy-observational-study-in-poland-17337https://curecurrent.com/trials/the-characteristics-of-different-personal-lancets-on-blood-volume-and-perceived-pain-in-patients-with-diabetes-mellitus-17338https://curecurrent.com/trials/comparison-of-three-lancing-devices-regarding-capillary-blood-volume-and-lancing-pain-intensity-17339https://curecurrent.com/trials/a-clinical-trial-to-evaluate-the-pharmacokinetics-and-safety-tolerability-of-fimasartan-and-linagliptin-in-healthy-volun-17340https://curecurrent.com/trials/intervention-to-improve-the-adherence-in-community-pharmacies-17341https://curecurrent.com/trials/effects-of-telemonitoring-and-telemedicine-service-for-type-2-diabetes-care-17342https://curecurrent.com/trials/evaluation-of-risk-factors-for-gestational-diabetes-mellitus-17343https://curecurrent.com/trials/the-multi-ethnic-lifestyle-study-17344https://curecurrent.com/trials/the-cardiovascular-and-renal-effects-of-moringa-oleifera-extracts-and-stevia-rebaudiana-bertoni-in-patients-with-type-ii-17345https://curecurrent.com/trials/the-diabetic-retinopathy-screening-prevention-and-control-program-17346https://curecurrent.com/trials/ppar-rxr-and-vdr-expressions-in-diabetes-17347https://curecurrent.com/trials/metabolomic-profiling-of-in-patients-with-type2-diabetes-17348https://curecurrent.com/trials/the-effects-of-reducing-prolonged-sitting-bouts-in-individuals-at-high-risk-of-or-with-type-2-diabetes-17349https://curecurrent.com/trials/development-of-a-structured-education-programme-for-women-with-polycystic-ovary-syndrome-17350https://curecurrent.com/trials/sglt-2-inhibitor-empagliflozin-effects-on-appetite-and-weight-regulation-17351https://curecurrent.com/trials/vaporous-hyperoxia-therapy-vht-in-the-treatment-of-foot-wounds-17352https://curecurrent.com/trials/analysing-differences-in-glycaemic-control-immediately-post-obesity-surgery-the-adipose-study-17353https://curecurrent.com/trials/arming-health-can-breaking-up-restful-sitting-time-with-upper-body-contractile-activity-regulate-metabolic-health-17354https://curecurrent.com/trials/assessment-of-response-rates-and-yields-for-two-tools-for-early-detection-of-non-diabetic-hyperglycaemia-and-diabetes-17355https://curecurrent.com/trials/the-efficacy-and-safety-profile-of-capsaicin-8-patch-versus-5-lidocaine-patch-in-males-with-diabetic-neuropathy-17356https://curecurrent.com/trials/the-effects-of-an-8-week-vegan-diet-on-tmao-levels-and-post-challenge-glucose-levels-in-individuals-with-dysglycaemia-17357https://curecurrent.com/trials/the-impact-of-glucose-lowering-therapies-on-circulating-endothelial-progenitor-cells-and-its-mobilising-factor-stromal-d-17358https://curecurrent.com/trials/fit-2-sit-are-metabolic-responses-to-sitting-light-breaks-mediated-by-fitness-17359https://curecurrent.com/trials/canagliflozin-invokana-vs-standard-dual-therapy-regimen-for-t2dm-during-ramadan-17360https://curecurrent.com/trials/trial-for-people-with-established-type-2-diabetes-during-ramadan-17361https://curecurrent.com/trials/the-reversal-intervention-for-metabolic-syndrome-study-17362https://curecurrent.com/trials/effects-of-liraglutide-in-young-adults-with-type-2-diabetes-lydia-17363https://curecurrent.com/trials/cardiovascular-risk-in-toledo-population-17364https://curecurrent.com/trials/influence-of-prior-walking-on-postprandial-metabolism-in-centrally-obese-men-17365https://curecurrent.com/trials/nash-and-type-2-diabetes-role-of-the-receptor-activator-of-nuclear-factor-b-rank-and-its-ligand-rankl-17366https://curecurrent.com/trials/prevalence-of-oral-mucosal-alterations-in-diabetes-mellitus-type2-17367https://curecurrent.com/trials/effects-of-mild-hypoglycaemia-on-cognitive-function-in-type-2-diabetes-17368https://curecurrent.com/trials/the-current-health-status-of-patients-living-with-type-1-diabetes-from-the-lmc-diabetes-patient-registry-17369https://curecurrent.com/trials/evaluation-of-non-surgical-periodontal-therapy-in-diabetic-patients-17370https://curecurrent.com/trials/trial-comparing-metabolic-efficiency-of-islet-graft-to-intensive-insulin-therapy-for-type-1-diabetes-s-treatment-17371https://curecurrent.com/trials/application-of-new-technologies-and-tools-to-nutrition-research-17372https://curecurrent.com/trials/elo-water-in-diabetes-care-for-enhancement-of-blood-sugar-control-17373https://curecurrent.com/trials/the-role-of-glucose-dependent-insulinotropic-polypeptide-in-the-pathological-glucose-homeostasis-of-type-1-diabetes-17374https://curecurrent.com/trials/safety-tolerability-and-pharmacodynamics-of-ionis-dgat2rx-in-adult-patients-with-type-2-diabetes-17375https://curecurrent.com/trials/switching-from-insulin-to-sulfonylurea-in-diabetes-associated-with-variants-in-mody-genes-17376https://curecurrent.com/trials/phthalates-exposure-in-type-2-diabetic-patients-and-diuretic-therapy-17377https://curecurrent.com/trials/audio-health-engagement-analysis-in-diabetes-the-ahead-study-17378https://curecurrent.com/trials/glycated-albumin-in-pregnancy-17379https://curecurrent.com/trials/pharmacist-led-medication-review-with-follow-up-on-primary-care-cardiovascular-older-adult-patients-17380https://curecurrent.com/trials/internet-based-exercise-training-in-type-2-diabetes-17381https://curecurrent.com/trials/glycemic-control-and-iron-status-in-diabetic-pregnancies-a-study-of-new-markers-17382https://curecurrent.com/trials/studying-on-the-difference-between-two-kinds-of-osteomyelitis-17383https://curecurrent.com/trials/evidence-based-laboratory-test-order-sets-in-primary-care-17384https://curecurrent.com/trials/effect-of-perioperative-glycemia-protocol-on-glycemic-outcomes-in-diabetic-patients-undergoing-abdominal-surgery-17385https://curecurrent.com/trials/optimized-stenting-using-intravascular-ultrasound-ivus-in-long-lesion-rationale-for-simplified-criteria-17386https://curecurrent.com/trials/efficacy-of-automated-bolus-calculation-in-type-2-diabetes-17387https://curecurrent.com/trials/clinical-trial-for-the-investigational-drug-pb-201-in-subjects-with-type-2-diabetes-mellitus-17388https://curecurrent.com/trials/dose-finding-of-pb-119-administered-subcutaneously-once-weekly-versus-placebo-in-drug-na-ve-t2dm-subjects-17389https://curecurrent.com/trials/glucose-containing-and-glucose-free-hemodialysate-in-type-2-diabetic-patients-17390https://curecurrent.com/trials/cynara-scolymus-extract-for-treatment-of-diabetes-mellitus-type-2-17391https://curecurrent.com/trials/dyslipidemia-prevalence-perception-treatment-and-awareness-in-the-tunisian-population-17392https://curecurrent.com/trials/optimal-type-2-diabetes-management-including-benchmarking-and-standard-treatment-17393https://curecurrent.com/trials/psychological-distress-and-type-2-diabetes-17394https://curecurrent.com/trials/hybrid-coronary-revascularization-in-diabetics-17395https://curecurrent.com/trials/does-early-weight-loss-following-laparoscopic-sleeve-gastrectomy-affect-long-term-outcomes-17396https://curecurrent.com/trials/effect-of-self-and-family-management-of-diabetic-foot-ulcers-programs-on-health-outcomes-17397https://curecurrent.com/trials/pk-pd-biosimilarity-study-of-gan-lee-insulin-glargine-injection-vs-us-eu-lantus-in-type-1-diabetes-mellitus-patients-17398https://curecurrent.com/trials/postprandial-metabolites-of-meal-challenge-test-in-diabetes-state-17399https://curecurrent.com/trials/study-of-minimed-640g-insulin-pump-with-smartguard-in-prevention-of-low-glucose-events-in-adults-with-type-1-diabetes-17400https://curecurrent.com/trials/hypertension-and-diabetes-mellitus-community-management-center-had-come-project-17401https://curecurrent.com/trials/diabetes-self-management-education-programme-in-thailand-17402https://curecurrent.com/trials/effect-of-lipid-lowering-agents-on-diabetic-retinopathy-and-cardiovascular-risk-of-diabetic-patients-17403https://curecurrent.com/trials/continuous-subcutaneous-insulin-infusion-versus-multiple-dose-insulin-injections-in-routine-clinical-practice-17404https://curecurrent.com/trials/gastric-ultrasound-of-diabetic-and-non-diabetic-patients-following-preoperative-fasting-instructions-17405https://curecurrent.com/trials/diabetes-research-on-patient-stratification-17406https://curecurrent.com/trials/resistance-exercise-on-postprandial-hyperglycemia-in-patients-with-b-thalassemia-exhibiting-resistance-to-insulin-17407https://curecurrent.com/trials/assessment-of-the-safety-tolerability-and-pharmacodynamics-after-administration-of-one-dose-of-azd8601-to-male-patients-17408https://curecurrent.com/trials/efficacy-and-safety-of-deep-sea-water-on-the-blood-glucose-level-17409https://curecurrent.com/trials/efficacy-of-ace-inhibitors-mras-and-ace-inhibitor-mra-combination-17410https://curecurrent.com/trials/digital-integrated-healthcare-platform-in-patients-with-type-2-diabetes-17411https://curecurrent.com/trials/genetic-contribution-to-the-pathophysiology-of-the-charcot-foot-in-qatari-patients-with-diabetes-17412https://curecurrent.com/trials/inulin-and-acetate-production-and-human-substrate-metabolism-17413https://curecurrent.com/trials/ultrasound-measure-of-gastric-volume-in-diabetic-and-non-diabetic-patients-before-general-anesthesia-17414https://curecurrent.com/trials/effect-of-cytosorb-on-blood-levels-of-inflammatory-biomarkers-of-sepsis-17415https://curecurrent.com/trials/study-of-medi0382-in-combination-with-dapagliflozin-and-metformin-in-overweight-obese-participants-with-type-2-diabetes-17416https://curecurrent.com/trials/beta-glucan-and-acetate-production-17417https://curecurrent.com/trials/evaluation-of-losartan-and-perindopril-in-blacks-type-2-diabetics-patients-17418https://curecurrent.com/trials/study-of-association-of-salivary-adipokines-with-prediabetes-and-type-2-diabetes-mellitus-17419https://curecurrent.com/trials/a-clinical-trial-to-investigate-the-pharmacokinetics-and-safety-tolerability-of-ckd-386-in-healthy-adult-volunteers-17420https://curecurrent.com/trials/the-cardiovascular-effects-of-ginger-zingiber-officinale-in-patients-with-type-ii-diabetes-mellitus-17421https://curecurrent.com/trials/treatment-of-latent-autoimmune-diabetes-of-the-adult-17422https://curecurrent.com/trials/a-research-study-to-look-at-similarity-between-semaglutide-versions-in-different-injection-tools-17423https://curecurrent.com/trials/a-clinical-study-to-evaluate-the-pharmacokinetics-safety-and-tolerability-of-ckd-375-17424https://curecurrent.com/trials/type-2-diabetes-patients-with-renal-impairment-17425https://curecurrent.com/trials/glucophage-extended-release-gxr-china-bioequivalence-study-nantong-darmstadt-17426https://curecurrent.com/trials/omnigen-dfu-pilot-study-17427https://curecurrent.com/trials/a-trial-to-compare-blood-concentration-levels-of-semaglutide-following-subcutaneous-injections-of-semaglutide-1-mg-by-2-17428https://curecurrent.com/trials/inpatient-blood-glucose-control-in-taichung-veterans-general-hospital-17429https://curecurrent.com/trials/screen-of-dm-by-ogtt-in-subjects-receiving-cag-or-mdct-for-cad-17430https://curecurrent.com/trials/effect-of-eswt-on-ed-in-type-2-diabetics-17431https://curecurrent.com/trials/exercise-using-chinese-yoga-improving-insomnia-17432https://curecurrent.com/trials/fetuin-a-as-a-marker-in-obesity-and-type-2-diabetes-mellitus-17433https://curecurrent.com/trials/impacts-of-glucose-forecasting-17434https://curecurrent.com/trials/role-of-helicobacter-pylori-in-microalbuminuria-17435https://curecurrent.com/trials/to-assess-the-bioequivalence-of-test-oral-formulation-of-alpha-lipoic-acid-600-mg-hr-film-coated-tablets-of-ilko-ilac-sa-17436https://curecurrent.com/trials/junior-kickoff-diabetes-education-for-children-under-11-years-17437https://curecurrent.com/trials/healthy-lifestyle-intervention-on-diabetes-risk-reduction-among-bruneian-young-adults-17438https://curecurrent.com/trials/the-effect-of-chlorella-supplementation-on-patients-with-type-2-diabetes-mellitus-17439https://curecurrent.com/trials/multiple-ascending-doses-of-globalagliatin-hydrochloride-in-type-2-diabetes-mellitus-17440https://curecurrent.com/trials/prospective-diabetes-registry-of-patients-with-type-2-diabetes-mellitus-on-sglt-2-inhibitor-therapy-in-singapore-17441https://curecurrent.com/trials/evaluation-of-idecide-a-smartphone-app-for-insulin-dosing-accounting-for-alcohol-and-exercise-17442https://curecurrent.com/trials/effect-of-sglt2-inhibition-on-oct-a-parameters-in-diabetic-ckd-17443https://curecurrent.com/trials/feasibility-study-to-evaluate-the-hybrid-logic-closed-loop-system-in-type-1-diabetes-the-dreamed-trail-17444https://curecurrent.com/trials/bicycling-and-mortality-among-individuals-with-diabetesnutrition-epic-17445https://curecurrent.com/trials/cross-over-study-to-evaluate-the-safety-and-efficacy-of-night-closed-loop-control-using-the-md-logic-automated-insulin-d-17446https://curecurrent.com/trials/comparison-of-two-closed-loop-strategies-for-glucose-control-in-type-1-diabetes-the-dremed-trail-2-17447https://curecurrent.com/trials/personalized-automated-determination-of-insulin-pump-setting-for-subjects-with-type-1-diabetes-switching-from-mdi-to-pum-17448https://curecurrent.com/trials/observational-data-collection-study-for-subjects-with-diabetes-using-insulin-injections-17449https://curecurrent.com/trials/24-hour-blood-pressure-dynamics-and-autonomic-adrenergic-regulation-in-type-2-diabetics-17450https://curecurrent.com/trials/incidence-of-major-cardiovascular-events-in-diabetic-patients-with-acs-undergoing-coronary-angioplasty-and-treated-with-17451https://curecurrent.com/trials/promoting-insulin-initiation-among-suboptimal-diabetic-control-patients-17452https://curecurrent.com/trials/immediate-effect-of-whole-body-vibration-on-diabetics-and-non-diabetics-17453https://curecurrent.com/trials/evaluating-a-digital-diabetes-education-program-17454https://curecurrent.com/trials/safety-and-tolerability-study-of-medi0382-in-japanese-preobese-or-obese-subjects-with-type-2-diabetes-17455https://curecurrent.com/trials/exercise-is-medicine-a-pilot-study-17456https://curecurrent.com/trials/metformin-and-systemic-inflammation-in-hiv-17457https://curecurrent.com/trials/effects-of-fenofibrate-on-endothelial-progenitor-cells-in-diabetes-17458https://curecurrent.com/trials/plerixafor-in-diabetic-wound-healing-17459https://curecurrent.com/trials/role-of-tlr2-and-tlr4-in-stage-2-periodontitis-patients-17460https://curecurrent.com/trials/effect-of-probiotic-co-administration-with-omega-3-fatty-acids-on-nafld-17461https://curecurrent.com/trials/effect-of-probiotic-on-insulin-resistance-in-type-2-diabetes-patients-17462https://curecurrent.com/trials/healthy-lifestyle-in-pregnancy-17463https://curecurrent.com/trials/vascular-function-fish-protein-hydrolysates-and-type-2-diabetes-mellitus-17464https://curecurrent.com/trials/effect-of-therapeutic-monitoring-on-blood-glucose-control-in-type-2-diabetes-17465https://curecurrent.com/trials/time-restricted-feeding-on-glucose-homeostasis-and-quality-of-life-17466https://curecurrent.com/trials/a-study-of-single-and-repeated-doses-of-glucagon-administered-to-participants-with-diabetes-17467https://curecurrent.com/trials/clinical-trial-to-evaluate-the-effect-of-an-extract-of-sclerocaya-birrea-on-prediabetic-subjects-17468https://curecurrent.com/trials/study-to-develop-a-kinetic-model-for-fdg-and-me4fdg-in-kidneys-of-type-2-diabetic-patients-17469https://curecurrent.com/trials/fluid-kinetics-in-patients-with-diabetic-ketoacidosis-17470https://curecurrent.com/trials/performance-evaluation-of-a-novel-non-invasive-glucometer-calibrated-against-validated-interstitial-glucose-references-17471https://curecurrent.com/trials/dapagliflozin-vs-empagliflozin-on-flow-mediated-dilation-in-type-2-diabetes-mellitus-17472https://curecurrent.com/trials/fetal-myocardial-performance-index-in-diabetic-pregnancies-17473https://curecurrent.com/trials/use-of-cgm-for-diabetes-management-following-a-hospitalization-17474https://curecurrent.com/trials/exploring-nutritype-signature-of-type-2-diabetes-risks-in-women-post-gestational-diabetes-mellitus-17475https://curecurrent.com/trials/resilient-a-research-study-looking-at-how-ryzodeg-works-in-people-with-type-2-diabetes-in-local-clinical-practice-in-jap-17476https://curecurrent.com/trials/a-canadian-study-of-the-effectiveness-of-tresiba-insulin-degludec-after-switching-basal-insulin-in-a-population-with-typ-17477https://curecurrent.com/trials/clinical-validation-through-analytical-study-with-urine-samples-to-compare-the-effectiveness-and-security-of-an-intellig-17478https://curecurrent.com/trials/new-concepts-in-diabetic-macular-edema-dme-17479https://curecurrent.com/trials/sleep-apnea-in-type-1-diabetes-17480https://curecurrent.com/trials/effects-of-artificial-sweeteners-on-glucose-metabolism-in-patients-with-type-2-diabetes-17481https://curecurrent.com/trials/videolaryngoscopy-vs-direct-laryngoscopy-for-intubation-in-patients-with-diabetes-17482https://curecurrent.com/trials/home-base-kidney-care-in-zuni-indians-17483https://curecurrent.com/trials/non-invasive-glucose-measurement-with-raman-technology-in-patients-with-type-1-and-type-2-diabetes-17484https://curecurrent.com/trials/database-and-calibration-of-a-non-invasive-glucose-monitoring-device-17485https://curecurrent.com/trials/the-hypoglycemic-effect-of-cyclocarya-paliurus-extract-on-hyperglycemic-populations-17486https://curecurrent.com/trials/anglo-scandinavian-cardiac-outcomes-trial-post-trial-follow-up-study-17487https://curecurrent.com/trials/incidence-of-type-2-diabetes-in-the-di-bet-es-study-17488https://curecurrent.com/trials/an-audit-of-the-impact-of-tailored-information-delivered-via-a-digital-learning-platform-17489https://curecurrent.com/trials/effect-of-escalating-oral-vitamin-d-replacement-on-homa-ir-in-vitamin-d-deficient-type-2-diabetics-17490https://curecurrent.com/trials/effects-of-dapagliflozin-on-central-hemodynamics-and-urine-albumin-excretion-in-patients-with-type-2-diabetes-17491https://curecurrent.com/trials/the-impact-of-almond-nut-consumption-on-markers-of-cvd-metabolic-health-17492https://curecurrent.com/trials/environmental-factors-and-embryonic-development-project-17493https://curecurrent.com/trials/the-health-action-process-approach-and-movement-patterns-in-adult-office-workers-17494https://curecurrent.com/trials/an-efficacy-study-of-canagliflozin-or-sitagliptin-to-determine-glucose-variability-in-mexican-participants-with-type-2-d-17495https://curecurrent.com/trials/tumor-necrosis-factor-alpha-and-interleukin-18-levels-in-children-with-gingivitis-and-type-1-diabetes-mellitus-17496https://curecurrent.com/trials/anti-oxidant-enzymes-and-total-antioxidant-levels-in-diabetes-mellitus-type-ii-patients-and-healthy-individuals-with-per-17497https://curecurrent.com/trials/investigation-for-health-efficacy-of-infrared-c-radiation-on-diabetes-patients-in-senior-s-activity-center-17498https://curecurrent.com/trials/primary-care-clinicians-responses-to-a-hypoglycemia-risk-calculator-for-diabetes-mellitus-in-ambulatory-care-17499https://curecurrent.com/trials/randomized-trial-comparing-colesevelam-vs-ezetimibe-17500https://curecurrent.com/trials/effect-of-fermentable-carbohydrate-on-glucose-homeostasis-17501https://curecurrent.com/trials/the-evaluation-of-effect-of-sanyinjiao-sp6-acupressure-on-early-diabetic-nephropathy-17502https://curecurrent.com/trials/effects-of-once-and-twice-daily-dosing-regimen-of-ertugliflozin-pf-04971729-mk-8835-in-participants-with-type-2-diabetes-17503https://curecurrent.com/trials/testing-the-effects-of-singapore-s-front-of-pack-healthier-choice-symbol-label-with-or-without-a-physical-activity-equiv-17504https://curecurrent.com/trials/introducing-cgm-at-type-1-diabetes-diagnosis-17505https://curecurrent.com/trials/alogliptin-tablets-special-drug-use-surveillance-mild-type-2-diabetes-mellitus-17506https://curecurrent.com/trials/clinical-assessment-of-a-novel-microprobe-array-continuous-glucose-monitor-for-type-1-diabetes-17507https://curecurrent.com/trials/evaluation-of-drug-interactions-of-saxagliptin-with-sildenafil-in-healthy-volunteers-17508https://curecurrent.com/trials/cgm-precision-and-glycaemic-variability-17509https://curecurrent.com/trials/influence-of-diabetes-control-on-treatment-of-diabetic-macular-edema-with-ranibizumab-17510https://curecurrent.com/trials/evaluation-of-long-term-implanted-sensor-in-patients-on-quality-of-life-17511https://curecurrent.com/trials/a-study-to-investigate-different-doses-of-0382-in-overweight-and-obese-subjects-with-type-2-diabetes-mellitus-17512https://curecurrent.com/trials/an-international-non-interventional-cohort-study-to-evaluate-the-safety-of-treatment-with-insulin-detemir-in-pregnant-wo-17513https://curecurrent.com/trials/alogliptin-tablets-special-drug-use-surveillance-type-2-diabetes-mellitus-monotherapy-combination-therapy-with-gi-17514https://curecurrent.com/trials/work-site-intervention-study-to-prevent-diabetes-in-nepal-17515https://curecurrent.com/trials/a-trial-to-investigate-the-single-dose-pharmacokinetics-of-insulin-degludec-liraglutide-compared-with-insulin-degludec-a-17516https://curecurrent.com/trials/impact-of-hypoglycaemia-in-patients-with-diabetes-mellitus-type-2-on-platelet-activation-17517https://curecurrent.com/trials/autologous-adult-stem-cells-to-patients-with-type-1-diabetes-and-a-successful-renal-transplant-17518https://curecurrent.com/trials/insulin-treatment-in-diabetic-older-people-with-heart-failure-17519https://curecurrent.com/trials/the-effects-of-crocin-supplementation-on-metabolic-parameters-oxidative-stress-amp-activated-protein-kinase-and-inflamma-17520https://curecurrent.com/trials/research-study-comparing-different-tablets-with-the-study-medicine-semaglutide-in-healthy-men-17521https://curecurrent.com/trials/a-study-to-demonstrate-the-bioequivalence-of-sitagliptin-metformin-combination-tablets-and-concomitant-administration-of-17522https://curecurrent.com/trials/efficacy-of-metformin-in-preventing-glucocorticoid-induced-diabetes-in-patients-with-brain-metastases-17523https://curecurrent.com/trials/impact-on-hypoglycaemia-awareness-of-real-time-cgm-and-intermittent-continuous-glucose-data-17524https://curecurrent.com/trials/long-term-implantable-sensor-improves-health-outcomes-in-patients-with-t1d-17525https://curecurrent.com/trials/pharmacokinetics-safety-and-tolerability-of-ckd-387-10-500mg-be-phase1-17526https://curecurrent.com/trials/phase-2a-study-to-evaluate-the-safety-and-efficacy-of-ph100-tablet-in-t2dm-patients-with-recent-cardiovascular-17527https://curecurrent.com/trials/hydroxybutyrate-glucose-metabolism-and-prediabetes-17528https://curecurrent.com/trials/alogliptin-tablets-specified-drug-use-survey-type-2-diabetic-patients-receiving-combination-therapy-with-a-hypoglycemic-17529https://curecurrent.com/trials/star-study-investigating-performance-and-safety-of-the-medical-device-sipore15-17530https://curecurrent.com/trials/efficacy-and-safety-of-garamycin-sponge-in-diabetic-patients-with-a-moderate-or-severe-foot-ulcer-infection-17531https://curecurrent.com/trials/effect-of-a-plant-based-hydrolysates-daily-consumption-on-the-hba1c-of-pre-diabetic-subjects-17532https://curecurrent.com/trials/pain-during-pars-plana-vitrectomy-with-sub-tenon-anesthesia-17533https://curecurrent.com/trials/study-of-real-world-evidence-with-sglt2i-dapagliflozin-and-dpp4i-sitagliptin-in-type-2-diabetes-patients-in-spain-17534https://curecurrent.com/trials/arterial-composition-and-cardiovascular-outcome-in-diabetes-17535https://curecurrent.com/trials/role-of-allopurinol-on-oxidative-stress-and-mitochondrial-alterations-in-skeletal-muscle-of-diabetic-patients-17536https://curecurrent.com/trials/solahmo-radio-stories-about-children-s-healthy-eating-and-exercise-17537https://curecurrent.com/trials/clinical-assessment-of-a-closed-loop-system-with-glucagon-exercise-and-mixed-meals-17538https://curecurrent.com/trials/impact-of-a-multidisciplinary-therapeutic-education-program-being-set-up-for-patients-with-type-2-diabetes-mellitus-17539https://curecurrent.com/trials/effect-of-phytoecdysterone-administration-in-subjects-with-prediabetes-17540https://curecurrent.com/trials/treatment-of-diabetic-foot-ulcers-with-inforatio-technique-to-promote-wound-healing-17541https://curecurrent.com/trials/intensive-cognitive-and-physical-rehabilitation-program-17542https://curecurrent.com/trials/community-based-lifestyle-intervention-for-primary-and-secondary-prevention-of-diabetes-in-arab-women-in-east-jerusalem-17543https://curecurrent.com/trials/the-effect-of-viscous-fiber-on-glycemic-control-in-individuals-with-diabetes-17544https://curecurrent.com/trials/antiischemic-effects-of-empagliflozin-in-diabetic-patients-with-refractory-angina-17545https://curecurrent.com/trials/retrospective-and-prospective-study-on-professional-continuous-glucose-monitoring-in-insulin-treated-type-2-diabetes-17546https://curecurrent.com/trials/study-of-chiglitazar-compare-with-placebo-in-type-2-diabetes-patients-17547https://curecurrent.com/trials/effects-of-replacing-diet-beverages-with-water-on-weight-loss-and-plasma-glucose-control-in-type-2-diabetes-17548https://curecurrent.com/trials/methylation-of-dna-in-children-and-adolescents-with-type-1-diabetes-mellitus-methyldiab-17549https://curecurrent.com/trials/effect-of-low-dose-combination-of-linagliptin-metformin-to-prevent-diabetes-17550https://curecurrent.com/trials/energy-balance-following-islet-transplantation-17551https://curecurrent.com/trials/p4-approach-in-diabetes-type-2-17552https://curecurrent.com/trials/study-of-chiglitazar-compare-with-sitagliptin-in-type-2-diabetes-patients-17553https://curecurrent.com/trials/physiotherapy-program-for-managing-adhesive-capsulitis-in-patients-with-diabetes-17554https://curecurrent.com/trials/using-virtual-counselors-to-overcome-genetic-literacy-barriers-17555https://curecurrent.com/trials/a-cross-sectional-survey-to-evaluate-diabetes-management-control-complications-psychosocial-aspects-of-patients-with-typ-17556https://curecurrent.com/trials/glucose-control-during-labour-in-gestational-diabetes-mellitus-with-insulin-treatment-a-randomized-controlled-trial-17557https://curecurrent.com/trials/dietary-management-of-gestational-diabetes-in-obese-pregnant-women-17558https://curecurrent.com/trials/algorithm-to-control-postprandial-post-exercise-and-night-glucose-excursions-in-a-portable-closed-loop-format-17559https://curecurrent.com/trials/a-randomized-control-trial-in-people-with-type-1-diabetes-who-will-fast-ramadan-does-insulin-timing-and-dose-matter-17560https://curecurrent.com/trials/effect-of-apple-cider-vinegar-and-metformin-combination-vs-metformin-alone-in-type-2-diabetics-17561https://curecurrent.com/trials/effect-of-empagliflozin-linagliptin-metformin-lifestyle-in-patients-with-prediabetes-17562https://curecurrent.com/trials/effects-of-sglt2-inhibition-treatment-on-different-levels-of-albuminuria-in-patients-with-type-2-diabetes-17563https://curecurrent.com/trials/insulin-sensitivity-in-patients-with-atopic-dermatitis-17564https://curecurrent.com/trials/effect-of-weight-loss-surgery-on-stem-cells-17565https://curecurrent.com/trials/nurse-led-continuum-of-care-for-people-with-diabetes-and-pre-diabetes-in-nepal-17566https://curecurrent.com/trials/quantification-of-cd163-inflammatory-biomarker-in-chronic-periodontitis-and-diabetic-subjects-17567https://curecurrent.com/trials/mobile-health-application-for-diabetes-17568https://curecurrent.com/trials/preliminary-exploration-on-the-operational-standards-of-insulin-pump-installation-in-diabetes-clinic-in-china-17569https://curecurrent.com/trials/single-non-fasting-ogtt-versus-fasting-ogtt-for-screening-of-hyperglycaemia-in-pregnancy-hip-17570https://curecurrent.com/trials/risk-assessment-of-type-2-diabetes-in-pharmacies-17571https://curecurrent.com/trials/the-effect-of-sodium-zirconium-cyclosilicate-on-albuminuria-in-patients-with-type-2-diabetes-and-hyperkalemia-17572https://curecurrent.com/trials/high-resolution-retina-imaging-17573https://curecurrent.com/trials/effects-of-metformin-on-hepatic-ffa-metabolism-17574https://curecurrent.com/trials/post-marketing-surveillance-special-use-results-surveillance-on-long-term-use-with-ryzodeg-17575https://curecurrent.com/trials/dbpr108-tablets-in-type-2-diabetes-mellitus-patients-17576https://curecurrent.com/trials/research-study-comparing-a-new-medicine-semaglutide-to-liraglutide-in-people-with-type-2-diabetes-17577https://curecurrent.com/trials/exergaming-versus-aerobic-exercises-on-mild-cognitive-impairment-17578https://curecurrent.com/trials/dpp4inhibitors-in-type-1-diabetes-17579https://curecurrent.com/trials/use-of-diazoxide-in-acute-hypoglycaemia-17580https://curecurrent.com/trials/a-study-of-single-or-repeated-doses-of-glucagon-in-participants-with-diabetes-17581https://curecurrent.com/trials/fecal-microbiome-transplantation-fmt-for-type-1-diabetes-17582https://curecurrent.com/trials/single-ascending-oral-doses-of-sy-008-in-healthy-subjects-17583https://curecurrent.com/trials/single-ascending-oral-doses-of-sy-009-in-healthy-subjects-17584https://curecurrent.com/trials/impact-of-insulin-sensitivity-on-cardiovascular-risk-markers-during-10-20-years-of-follow-up-17585https://curecurrent.com/trials/the-role-of-scube-1-in-ischemia-reperfusion-injury-17586https://curecurrent.com/trials/effects-of-an-aquatic-physical-exercise-program-on-glycaemic-control-and-perinatal-outcomes-of-gestational-diabetes-stud-17587https://curecurrent.com/trials/effectiveness-of-motivational-interviewing-on-improving-care-for-type-2-diabetes-mellitus-patients-in-china-17588https://curecurrent.com/trials/therapeutic-effect-of-dapagliflozin-combined-with-csii-on-newly-diagnosed-type-2-diabetes-mellitus-17589https://curecurrent.com/trials/acute-effects-of-an-aquatic-physical-exercise-on-glycemic-control-of-gestational-diabetes-17590https://curecurrent.com/trials/use-of-gdf15-as-a-biomarker-for-early-diagnosis-of-dm-and-monitoring-of-progress-of-complications-in-asians-17591https://curecurrent.com/trials/a-study-of-nasal-glucagon-ly900018-in-japanese-participants-with-diabetes-mellitus-17592https://curecurrent.com/trials/preclinical-cardiomyopathy-and-autonomic-function-in-type-1-diabetes-17593https://curecurrent.com/trials/utilizing-glycaemic-index-an-investigation-of-the-glycaemia-and-cognition-in-type-2-diabetes-17594https://curecurrent.com/trials/tolvaptan-versus-fluid-restriction-in-siadh-17595https://curecurrent.com/trials/immunogenicity-safety-study-of-wockhardt-s-recombinant-insulin-analogue-in-type-1-diabetic-patients-17596https://curecurrent.com/trials/the-effect-of-choline-alfoscerate-on-improvement-of-cognitive-function-in-elderly-patients-with-diabetes-17597https://curecurrent.com/trials/impact-of-body-composition-and-exercise-on-clinical-metabolic-and-molecular-parameters-in-type-2-diabetics-in-qatar-17598https://curecurrent.com/trials/the-pre-d-trial-effect-of-dapagliflozin-metformin-and-physical-activity-in-pre-diabetes-17599https://curecurrent.com/trials/the-canadian-e-paradigm-exercise-physical-activity-and-diabetes-glucose-monitoring-protocol-17600https://curecurrent.com/trials/impact-of-breakfast-composition-on-glycemic-and-incretin-responses-in-individuals-with-type-2-diabetes-17601https://curecurrent.com/trials/corneal-confocal-microscopy-to-detect-diabetic-neuropathy-in-children-17602https://curecurrent.com/trials/evaluating-the-glycemic-control-with-vildagliptin-and-metformin-combination-therapy-17603https://curecurrent.com/trials/effect-of-l-arginine-on-microcirculation-myogenesis-and-angiogenesis-associated-with-aging-sarcopenia-and-diabetes-17604https://curecurrent.com/trials/investigating-the-safety-and-effectiveness-of-insulin-degludec-in-a-real-world-population-with-type-1-and-2-diabetes-mel-17605https://curecurrent.com/trials/a-randomized-placebo-controlled-double-blind-trial-to-investigate-whether-vitamin-k2-can-influence-arterial-calcificatio-17606https://curecurrent.com/trials/pms-of-trazenta-on-the-long-term-use-as-add-on-therapy-17607https://curecurrent.com/trials/evaluation-of-glycemic-changes-during-exercise-in-children-with-type-1-diabetes-17608https://curecurrent.com/trials/diabetes-mellitus-and-inflammatory-bowel-disease-17609https://curecurrent.com/trials/reducing-sedentary-behaviour-in-patients-with-type-ii-diabetes-17610https://curecurrent.com/trials/effect-of-vitamin-c-d-and-zinc-supplementation-on-the-immune-and-inflammatory-process-in-type-2-diabetic-subjects-17611https://curecurrent.com/trials/evaluation-of-patients-who-underwent-sleeve-gastrectomy-with-jejunoileal-anastomosis-for-the-treatment-of-morbid-obesity-17612https://curecurrent.com/trials/home-based-intervention-to-the-diabetics-17613https://curecurrent.com/trials/at247-novorapid-and-fiasp-in-glucose-clamp-study-17614https://curecurrent.com/trials/evaluation-of-a-physical-activity-referral-scheme-17615https://curecurrent.com/trials/effect-of-carbohydrate-distribution-on-blood-glucose-in-women-with-gestational-diabetes-mellitus-gdm-17616https://curecurrent.com/trials/intracellular-counter-regulatory-mechanisms-following-low-blood-glucose-17617https://curecurrent.com/trials/breath-for-better-health-study-17618https://curecurrent.com/trials/insulin-sensitivity-and-secretion-during-pregnancy-and-post-partum-in-women-with-gestational-diabetes-17619https://curecurrent.com/trials/approaches-to-therapy-escalation-in-t2d-17620https://curecurrent.com/trials/biomarkers-of-common-eye-diseases-17621https://curecurrent.com/trials/does-exercise-timing-affect-glucose-levels-in-people-with-diabetes-17622https://curecurrent.com/trials/effect-of-melatonin-and-metformin-on-glycemic-control-genotoxicity-and-cytotoxicity-markers-in-patients-with-prediabetes-17623https://curecurrent.com/trials/everolimus-eluting-bioresorbable-vascular-scaffolds-versus-everolimus-eluting-stents-in-patients-with-diabetes-mellitus-17624https://curecurrent.com/trials/glp-1-and-oxyntomodulin-release-in-relation-to-diet-in-type-2-diabetes-patients-17625https://curecurrent.com/trials/defining-the-molecular-and-physiological-mechanisms-of-pancreatic-islet-cell-dysfunction-which-lead-to-type-2-diabetes-17626https://curecurrent.com/trials/efficacy-of-ll-37-cream-on-bacteria-colonization-inflammation-response-and-healing-rate-of-diabetic-foot-ulcers-17627https://curecurrent.com/trials/effectiveness-of-pre-medical-consultation-diabetes-self-care-education-programme-on-glycemic-control-in-type-2-diabetes-17628https://curecurrent.com/trials/effectiveness-of-shared-care-diabetes-management-in-patients-with-type-2-diabetes-17629https://curecurrent.com/trials/dose-response-of-dance-501-in-subjects-with-type-2-diabetes-mellitus-17630https://curecurrent.com/trials/effects-of-an-amino-acid-and-chromium-picolinate-containing-drink-on-glucose-metabolism-17631https://curecurrent.com/trials/feasibility-study-of-dermgen-for-diabetic-foot-ulcer-treatment-17632https://curecurrent.com/trials/effectiveness-and-safety-study-of-the-percutaneous-optical-fibre-glucose-sensor-fibersense-17633https://curecurrent.com/trials/collection-of-human-liver-biopsy-and-whole-blood-samples-from-t1dm-tp-or-pp-patients-for-potential-use-for-insulin-produ-17634https://curecurrent.com/trials/a-study-to-compare-pharmacokinetics-and-pharmacodynamics-of-ringlar-to-lantus-in-type-1-diabetes-mellitus-patients-17635https://curecurrent.com/trials/effects-of-sglt2-inhibitors-on-islet-cell-function-and-insulin-sensitivity-in-patients-of-type-2-diabetes-mellitus-17636https://curecurrent.com/trials/a-study-of-dulaglutide-in-japanese-participants-with-type-2-diabetes-17637https://curecurrent.com/trials/safety-and-efficacy-of-a-novel-glucagon-formulation-in-type-1-diabetic-patients-following-insulin-induced-hypoglycemia-17638https://curecurrent.com/trials/effect-of-evogliptin-on-albuminuria-in-patients-with-type-2-diabetes-and-renal-insufficiency-17639https://curecurrent.com/trials/a-study-of-nasal-glucagon-in-participants-with-type-1-diabetes-mellitus-17640https://curecurrent.com/trials/comparing-the-accuracy-of-different-blood-glucose-monitoring-systems-cgm-and-fgm-17641https://curecurrent.com/trials/evaluating-the-impact-of-a-community-health-worker-program-in-neno-malawi-17642https://curecurrent.com/trials/budesonide-for-immunosuppression-after-liver-transplantation-to-reduce-side-effects-17643https://curecurrent.com/trials/a-study-to-compare-rosuvastatin-ezetimibe-and-rosuvastatin-in-patients-with-diabetes-mellitus-and-hypercholesterolemia-17644https://curecurrent.com/trials/plant-versus-animal-dietary-protein-and-the-effect-on-proteinuria-17645https://curecurrent.com/trials/fructose-in-exercising-individuals-with-type-1-diabetes-using-insulin-degludec-17646https://curecurrent.com/trials/neuromuscular-ultrasound-in-correlation-to-neurophysiological-findings-17647https://curecurrent.com/trials/effect-of-needle-free-jet-injection-of-insulin-on-glucose-control-and-injection-feelings-in-type-1-diabetic-patients-17648https://curecurrent.com/trials/cmr-in-type-2-diabetes-mellitus-patients-17649https://curecurrent.com/trials/extracorporeal-shock-wave-therapy-on-diabetes-related-frozen-shoulder-17650https://curecurrent.com/trials/omarigliptin-add-on-to-insulin-in-japanese-participants-with-type-2-diabetes-mellitus-t2dm-mk-3102-039-17651https://curecurrent.com/trials/correlation-between-exercise-and-insulin-dose-in-a-camp-for-pediatric-type-1-patients-17652https://curecurrent.com/trials/network-based-approach-in-type-2-diabetes-and-its-cardiovascular-risk-17653https://curecurrent.com/trials/evaluation-of-efficacy-and-safety-of-insulin-glargine-injected-by-needle-free-jet-syringe-17654https://curecurrent.com/trials/network-medicine-epigenetics-and-obesity-17655https://curecurrent.com/trials/negative-pressure-wound-therapy-in-the-management-of-diabetic-foot-ulcers-17656https://curecurrent.com/trials/a-study-comparing-the-effects-and-safety-of-dulaglutide-with-insulin-glargine-in-type-2-diabetes-mellitus-17657https://curecurrent.com/trials/a-study-comparing-the-effects-and-safety-of-dulaglutide-with-glimepiride-in-type-2-diabetes-mellitus-17658https://curecurrent.com/trials/long-term-daily-use-of-trazenta-tablets-in-patients-with-type-2-diabetes-mellitus-17659https://curecurrent.com/trials/meta-analysis-of-the-nordic-dietary-pattern-on-cardiometabolic-risk-and-cardiovascular-outcomes-17660https://curecurrent.com/trials/self-care-management-programme-for-type-2-adult-dm-patients-with-poor-glycemic-control-17661https://curecurrent.com/trials/pain-in-neuropathy-study-17662https://curecurrent.com/trials/sit-less-move-more-at-work-mhealth-intervention-on-office-employees-with-diabetes-type-2-17663https://curecurrent.com/trials/efficacy-and-safety-study-of-pitavastatin-compared-to-atorvastatin-in-type-2-diabetes-mellitus-with-hypercholesterolemia-17664https://curecurrent.com/trials/optical-coherence-tomography-angiography-oct-a-in-children-6-14-years-of-age-17665https://curecurrent.com/trials/diabetic-foot-ulcer-prevention-system-dfups-part-2-17666https://curecurrent.com/trials/startright-a-pilot-research-study-about-diabetes-diagnosis-treatment-17667https://curecurrent.com/trials/acute-mycoprotein-effect-on-glycaemic-control-in-south-asians-17668https://curecurrent.com/trials/the-imaging-genetic-study-of-type-2-diabetes-and-depression-17669https://curecurrent.com/trials/microcirculation-and-bone-metabolism-in-patients-with-type-2-diabetes-mellitus-and-charcot-foot-a-pilot-study-17670https://curecurrent.com/trials/diet-and-medical-therapy-versus-bariatric-surgery-in-type-2-diabetes-17671https://curecurrent.com/trials/a-study-of-the-glucodynamic-effects-of-dulaglutide-ly2189265-in-japanese-participants-with-type-2-diabetes-17672https://curecurrent.com/trials/switch-sensing-with-insulin-pump-therapy-to-control-hba1c-17673https://curecurrent.com/trials/a-randomized-trial-on-platelet-rich-plasma-versus-saline-dressing-of-diabetic-foot-ulcers-17674https://curecurrent.com/trials/effect-of-linagliptin-metformin-on-patients-who-do-not-achieve-normoglucemia-with-metformine-17675https://curecurrent.com/trials/gut-microbiome-and-gestational-diabetes-mellitus-17676https://curecurrent.com/trials/assessment-of-the-safety-of-foralumab-an-oral-anti-cd3-antibody-in-patients-with-nash-and-t2dm-17677https://curecurrent.com/trials/influence-of-nitrates-on-bone-remodeling-and-endothelial-function-in-patients-with-type-2-diabetes-mellitus-17678https://curecurrent.com/trials/the-milestone-study-17679https://curecurrent.com/trials/copeptin-relevance-as-a-perioperative-marker-in-pediatric-cardiac-surgery-17680https://curecurrent.com/trials/a-combined-biofeedback-virtual-reality-system-for-reduction-of-fear-of-hypoglycemia-17681https://curecurrent.com/trials/hypomagnesemia-and-diabetic-nephropathy-17682https://curecurrent.com/trials/using-nanotechnology-structured-water-to-control-blood-glucose-in-type-2-diabetic-patients-17683https://curecurrent.com/trials/a-study-on-comparison-of-glargine-plus-glulisine-with-premixed-insulin-in-type-2-diabetes-patients-17684https://curecurrent.com/trials/tcf7l2-gene-polymorphism-and-ages-in-diabetic-nephropathy-17685https://curecurrent.com/trials/screening-early-referral-and-lifestyle-tailored-e-prescription-for-cardiovascular-prevention-17686https://curecurrent.com/trials/effects-of-the-golo-for-life-system-diet-with-and-without-golo-release-supplement-on-glycemic-control-and-insulin-resist-17687https://curecurrent.com/trials/study-of-imcy-0098-in-patients-with-recent-onset-type-1-diabetes-17688https://curecurrent.com/trials/preventing-microalbuminuria-in-type-2-diabetes-17689https://curecurrent.com/trials/evaluation-of-minimed-670g-in-t1d-patients-on-multiple-daily-injection-17690https://curecurrent.com/trials/ddi-study-to-investigate-the-impact-of-itraconazole-on-the-pharmacokinetics-of-dorzagliatin-17691https://curecurrent.com/trials/cognitive-behavioral-therapy-cbt-in-children-with-diabetes-17692https://curecurrent.com/trials/impact-of-overfeeding-and-following-exercise-training-in-individuals-with-and-without-increased-risk-of-type-2-diabetes-17693https://curecurrent.com/trials/mesenchymal-stem-cells-transplantation-in-newly-diagnosed-type-1-diabetes-patients-17694https://curecurrent.com/trials/evaluate-the-immunogenicity-of-a-novel-glucagon-formulation-17695https://curecurrent.com/trials/implementation-of-a-multi-component-supervised-exercise-program-for-patients-with-type-2-diabetes-mellitus-17696https://curecurrent.com/trials/post-marketing-clinical-trial-of-kad-1229-in-patients-with-type-2-diabetes-mellitus-17697https://curecurrent.com/trials/basal-insulin-strategies-before-surgery-17698https://curecurrent.com/trials/effect-of-extra-virgin-olive-oil-on-postprandial-blood-glucose-in-type-2-diabetes-mellitus-patients-17699https://curecurrent.com/trials/involvement-of-dipeptidyl-peptidase-4-and-sodium-glucose-co-transporter-2-in-extrapancreatic-glucagon-secretion-17700https://curecurrent.com/trials/lifestyle-intervention-to-prevent-the-recurrence-of-gestational-diabetes-mellitus-17701https://curecurrent.com/trials/a-behavioral-intervention-to-prevent-gestational-diabetes-mellitus-17702https://curecurrent.com/trials/diabetes-and-psychological-profile-17703https://curecurrent.com/trials/effects-of-a-carbonated-water-enriched-with-amino-acids-and-chromium-picolinate-good-idea-on-glucose-homeostasis-17704https://curecurrent.com/trials/a-behavioral-intervention-to-prevent-impaired-glucose-tolerance-diabetes-mellitus-digital-i-17705https://curecurrent.com/trials/effect-of-butyrate-on-inflammation-and-albuminuria-in-patients-with-albuminuria-type-1-diabetes-and-intestinal-inflammat-17706https://curecurrent.com/trials/epigenetics-based-diagnosis-of-diabetes-in-saliva-and-blood-samples-17707https://curecurrent.com/trials/effect-of-dapagliflozin-on-nighttime-blood-pressure-in-type-2-diabetes-17708https://curecurrent.com/trials/the-effect-of-dietary-nitrate-on-blood-pressure-insulin-sensitivity-and-vascular-function-in-type-2-diabetes-17709https://curecurrent.com/trials/comparison-study-of-usual-care-vs-usual-care-plus-community-intervention-to-manage-type-2-diabetes-17710https://curecurrent.com/trials/exercise-training-improves-coronary-endothelial-dysfunction-in-diabetes-mellitus-type-2-and-coronary-artery-disease-17711https://curecurrent.com/trials/developing-and-testing-an-implementation-strategy-to-improve-perioperative-diabetes-care-17712https://curecurrent.com/trials/assessment-of-two-insulin-pump-insulin-delivery-systems-in-type-1-diabetes-17713https://curecurrent.com/trials/survey-of-people-with-diabetes-caregivers-of-people-with-diabetes-parents-of-children-and-young-people-with-diabetes-17714https://curecurrent.com/trials/the-individually-marked-panretinal-laser-photocoagulation-for-proliferative-diabetic-retinopathy-study-treat-17715https://curecurrent.com/trials/diabetic-retinopathy-and-subclinical-signs-of-disease-transition-17716https://curecurrent.com/trials/self-screening-of-cardiovascular-risk-17717https://curecurrent.com/trials/preventing-atopic-dermatitis-and-allergies-in-children-17718https://curecurrent.com/trials/food-effect-bioavailability-of-fixed-dose-combination-zemimet-sr-tab-50-1000-mg-under-fed-and-fasting-conditions-17719https://curecurrent.com/trials/the-use-of-allogenic-platelet-rich-plasma-for-the-treatment-of-diabetic-foot-ulcer-17720https://curecurrent.com/trials/randomized-evaluation-of-anagliptin-versus-sitagliptin-on-low-density-lipoprotein-cholesterol-in-diabetes-trial-17721https://curecurrent.com/trials/omarigliptin-mk-3102-clinical-trial-placebo-and-sitagliptin-controlled-monotherapy-study-in-japanese-patients-with-type-17722https://curecurrent.com/trials/clinical-characteristics-anti-hyperglycaemic-treatment-pattern-and-target-attainment-of-type-2-diabetes-mellitus-patient-17723https://curecurrent.com/trials/incidence-of-poorly-controlled-diabetes-in-surgical-population-17724https://curecurrent.com/trials/the-effect-of-water-intake-on-glucose-regulation-17725https://curecurrent.com/trials/skin-biopsy-in-the-diagnosis-of-small-fiber-neuropathy-in-chinese-patients-with-diabetes-17726https://curecurrent.com/trials/exenatide-compared-with-insulin-glargine-to-change-liver-fat-content-in-type-2-diabetes-17727https://curecurrent.com/trials/magnesium-supplementation-in-type-ii-diabetes-17728https://curecurrent.com/trials/almonds-and-diabetes-management-17729https://curecurrent.com/trials/ovarian-reserve-in-diabetes-mellitus-17730https://curecurrent.com/trials/effect-of-whole-body-vibration-on-tcpo2-17731https://curecurrent.com/trials/impact-of-a-health-and-mental-health-promotion-intervention-among-jordanians-and-syrians-17732https://curecurrent.com/trials/feasibility-and-safety-of-walking-football-in-patients-with-type-2-diabetes-17733https://curecurrent.com/trials/effects-of-functional-ingredients-in-an-acute-metabolic-challenge-context-17734https://curecurrent.com/trials/exercise-for-people-with-peripheral-neuropathy-and-diabetic-foot-ulcers-a-case-series-on-feasibility-and-safety-17735https://curecurrent.com/trials/oral-glucose-tolerance-test-and-post-partum-diagnosis-of-diabetes-mellitus-type-2-dt2-post-partum-17736https://curecurrent.com/trials/the-effect-of-insulin-induced-hypoglycaemia-on-gut-derived-glucagon-secretion-px-hypo-17737https://curecurrent.com/trials/implementation-and-evaluation-of-an-inpatient-diabetes-superuser-education-program-17738https://curecurrent.com/trials/impact-of-the-continuous-measurement-of-blood-glucose-on-insulin-pump-on-child-quality-of-life-with-type-1-diabetes-17739https://curecurrent.com/trials/a-pivotal-study-to-evaluate-enlite-sensor-performance-with-ipro-2-in-china-17740https://curecurrent.com/trials/doppler-ultrasound-investigation-of-microcirculations-17741https://curecurrent.com/trials/foxiga-korea-local-phase-4-study-17742https://curecurrent.com/trials/diabetes-em-movimento-community-based-lifestyle-intervention-program-for-patients-with-type-2-diabetes-17743https://curecurrent.com/trials/what-is-the-dose-response-of-varying-meal-content-of-fat-on-postprandial-glycaemia-in-children-with-t1dm-17744https://curecurrent.com/trials/cardiac-magnetic-resonance-for-asymptomatic-type-2-diabetics-with-cardiovascular-high-risk-catch-pilot-study-17745https://curecurrent.com/trials/adhesive-materials-for-continuous-glucose-monitoring-systems-17746https://curecurrent.com/trials/renal-effects-of-treatment-with-empagliflozin-alone-or-in-combination-with-semaglutide-in-patients-with-type-2-diabetes-17747https://curecurrent.com/trials/day-night-rhythm-in-muscle-metabolism-of-prediabetics-17748https://curecurrent.com/trials/euroaspire-v-survey-on-cardiovascular-disease-prevention-and-diabetes-17749https://curecurrent.com/trials/metronom-continuous-glucose-monitoring-system-17750https://curecurrent.com/trials/effect-of-empagliflozin-on-liver-fat-content-in-patients-with-type-2-diabetes-17751https://curecurrent.com/trials/coordinated-healthcare-for-complex-kids-17752https://curecurrent.com/trials/the-efficacy-of-mdi-treatment-with-an-optimization-algorithm-adjusting-basal-bolus-parameters-in-children-and-adolescent-17753https://curecurrent.com/trials/outcome-of-patients-with-thoraco-abdominal-injury-and-stress-induced-hyperglycemia-or-diabetic-hyperglycemia-17754https://curecurrent.com/trials/an-urban-trail-network-and-cardiovascular-disease-a-natural-experiment-17755https://curecurrent.com/trials/multiple-islet-peptide-administration-in-type-1-diabetes-multipept1de-17756https://curecurrent.com/trials/a-randomised-controlled-clinical-trial-in-type-2-diabetes-comparing-semaglutide-to-placebo-and-liraglutide-17757https://curecurrent.com/trials/preventing-recurrent-gestational-diabetes-with-metformin-17758https://curecurrent.com/trials/a-community-paramedicine-initiative-for-older-adults-living-in-subsidized-housing-chap-ems-cp-clinic-17759https://curecurrent.com/trials/systematic-evaluation-of-continuous-glucose-monitoring-data-17760https://curecurrent.com/trials/the-use-of-topical-nasal-steroids-for-skin-reactions-to-continuous-glucose-monitoring-system-among-children-and-youth-wi-17761https://curecurrent.com/trials/prematurity-prevalence-among-t1d-patients-and-its-characteristics-compared-with-premature-born-non-diabetic-patients-17762https://curecurrent.com/trials/hemoglobin-a1c-and-immediate-postsurgical-complications-diabetes-type-2-17763https://curecurrent.com/trials/cardiac-dysfunction-in-adolescents-with-type-1-diabetes-contribution-of-daily-life-glucoregulation-and-impact-on-cardior-17764https://curecurrent.com/trials/malaysia-diabetes-ramadan-nutrition-plan-my-dia-rnp-a-feasibility-study-17765https://curecurrent.com/trials/an-open-label-extended-clinical-protocol-of-ranibizumab-to-evaluate-safety-and-efficacy-in-rare-vegf-driven-ocular-disea-17766https://curecurrent.com/trials/diabetes-and-travel-evaluation-of-a-diabetes-education-module-a-randomized-controlled-trial-primo-travel-17767https://curecurrent.com/trials/diabetes-and-social-issues-evaluation-of-a-diabetes-education-module-17768https://curecurrent.com/trials/diabetes-and-partnership-evaluation-of-a-diabetes-education-module-17769https://curecurrent.com/trials/carbohydrate-restriction-in-pregnant-women-with-gestation-diabetes-mellitus-17770https://curecurrent.com/trials/lups-lipids-and-glucose-under-prospective-surveillance-17771https://curecurrent.com/trials/diabetes-and-sports-evaluation-of-a-diabetes-education-module-17772https://curecurrent.com/trials/smartphone-app-to-restore-optimal-weight-in-women-with-recent-gestational-diabetes-17773https://curecurrent.com/trials/copeptin-after-an-oral-stimulation-with-macimorelin-in-healthy-volunteers-17774https://curecurrent.com/trials/bioequivalence-study-for-gemigliptin-metformin-50-1000-mg-and-coadministration-of-gemigliptin-50-mg-and-metformin-1000-m-17775https://curecurrent.com/trials/a-study-of-ly2922083-in-healthy-participants-and-participants-with-diabetes-17776https://curecurrent.com/trials/empra-empagliflozin-and-ras-in-kidney-disease-17777https://curecurrent.com/trials/prediction-and-prevention-of-nocturnal-hypoglycemia-in-persons-with-type-1-diabetes-using-machine-learning-techniques-17778https://curecurrent.com/trials/empagliflozin-versus-sitagliptin-therapy-for-improvement-of-myocardial-perfusion-reserve-in-diabetic-patients-with-coron-17779https://curecurrent.com/trials/the-effects-of-mixed-grain-on-blood-glucose-and-insulin-in-healthy-male-17780https://curecurrent.com/trials/safe-ap-automatic-control-of-blood-glucose-under-announced-and-unannounced-exercise-17781https://curecurrent.com/trials/changes-in-incretins-response-and-glycemic-control-after-gastric-bypass-surgery-in-type-2-diabetic-patients-versus-healt-17782https://curecurrent.com/trials/hepatic-metabolic-changes-in-response-to-glucagon-infusion-17783https://curecurrent.com/trials/the-effect-of-cinnamon-cassia-on-diabetes-control-and-cardiometabolic-risk-factors-in-adults-with-type-2-diabetes-mellit-17784https://curecurrent.com/trials/study-with-dapagliflozin-17785https://curecurrent.com/trials/a-multi-center-trial-of-impact-chw-support-for-chronically-ill-patients-17786https://curecurrent.com/trials/effect-of-vitamins-d3-and-k2-in-uoc-and-insulin-serum-levels-in-patients-with-diabetes-mellitus-17787https://curecurrent.com/trials/a-study-to-evaluate-thr-317-and-ranibizumab-combination-treatment-for-diabetic-macular-oedema-dme-17788https://curecurrent.com/trials/the-effects-of-dapagliflozin-on-hdl-particles-subtypes-and-reverse-cholesterol-transport-in-type-2-diabetic-patients-17789https://curecurrent.com/trials/salud-y-vida-2-0-enhancing-integrated-behavioral-health-for-diabetics-in-the-rio-grande-valley-17790https://curecurrent.com/trials/study-of-oral-anthocyanins-on-insulin-resistance-17791https://curecurrent.com/trials/impact-of-lipoic-acid-use-on-stroke-outcome-after-reperfusion-therapy-in-patients-with-diabetes-important-17792https://curecurrent.com/trials/telemedical-devices-in-the-management-of-type-2-diabetes-mellitus-to-improve-diabetic-control-and-quality-of-life-17793https://curecurrent.com/trials/effect-of-lumacaftor-ivacaftor-on-glucose-handling-and-tolerance-in-cystic-fibrosis-phe508del-17794https://curecurrent.com/trials/time-restricted-feeding-for-improving-diabetes-risk-triffid-17795https://curecurrent.com/trials/infraclavicular-block-properties-in-diabetic-patients-17796https://curecurrent.com/trials/evaluation-of-south-africa-s-national-adherence-strategy-17797https://curecurrent.com/trials/pizza-leavening-and-postprandial-glycemia-in-type-1-diabetes-leaven-17798https://curecurrent.com/trials/effect-of-phacoemulsification-on-ocular-blood-flow-in-human-17799https://curecurrent.com/trials/estimate-rate-of-the-women-who-have-gestational-diabetes-17800https://curecurrent.com/trials/interdisciplinary-and-family-intervention-to-prevent-type-2-diabetes-17801https://curecurrent.com/trials/effects-of-empagliflozin-linagliptin-vs-metformin-insulin-glargine-on-renal-and-vascular-changes-in-type-2-diabetes-17802https://curecurrent.com/trials/effectiveness-of-insoles-provided-to-patients-with-diabetes-a-longitudinal-randomized-controlled-study-in-gothenburg-17803https://curecurrent.com/trials/dietitians-helping-patients-care-for-diabetes-enhanced-17804https://curecurrent.com/trials/study-of-the-analytical-performance-of-allegro-instrument-17805https://curecurrent.com/trials/impact-of-parental-perfectionistic-cognitions-self-compassion-intervention-effects-on-shame-in-child-health-context-17806https://curecurrent.com/trials/expression-of-the-inhibitory-receptors-on-lymphocytes-t-cells-after-lung-cancer-surgery-17807https://curecurrent.com/trials/mini-gastric-bypass-vs-roux-eny-gastric-bypass-17808https://curecurrent.com/trials/family-routines-healthy-families-17809https://curecurrent.com/trials/insulin-sensitivity-and-metabolomics-during-oral-administration-of-glucose-and-graded-intravenous-infusion-17810https://curecurrent.com/trials/the-effects-of-hesperidin-and-flaxseed-in-prediabetes-17811https://curecurrent.com/trials/effect-of-intracameral-dexamethasone-after-phacoemulsification-in-diabetics-on-corneal-endothelial-cell-density-17812https://curecurrent.com/trials/the-sensitivity-of-traditional-chinese-medical-diagnostic-tools-for-diabetic-retinopathy-diabetic-retinopathy-a-pilot-st-17813https://curecurrent.com/trials/pharmacokinetics-of-antiplatelet-drugs-in-diabetic-patients-17814https://curecurrent.com/trials/effects-of-respiratory-muscle-training-in-obese-women-17815https://curecurrent.com/trials/effects-of-empowerment-based-program-on-post-discharge-glycemic-control-and-foot-ulcer-17816https://curecurrent.com/trials/use-of-wharton-jelly-in-diabetic-nephropathy-17817https://curecurrent.com/trials/heidelberg-in-vivo-confocal-microscopy-to-evaluate-the-ocular-surface-disorders-of-healthy-and-diseased-individuals-17818https://curecurrent.com/trials/use-of-stem-cells-in-diabetes-mellitus-type-1-17819https://curecurrent.com/trials/metformin-sr-tablet-dulening-and-glucophage-in-patients-with-type-2-diabetes-17820https://curecurrent.com/trials/closed-loop-control-of-glucose-levels-artificial-pancreas-for-15-weeks-in-adolescents-and-adults-with-type-1-diabetes-17821https://curecurrent.com/trials/outcome-of-diabetes-education-among-renal-transplant-recipients-with-new-onset-diabetes-after-transplantation-nodat-17822https://curecurrent.com/trials/automated-fetal-weight-estimation-a-multicenter-validation-using-fractional-limb-volume-17823https://curecurrent.com/trials/type-1-diabetes-aerobic-and-resistance-exercise-t1-dare-17824https://curecurrent.com/trials/platelet-reactivity-b-amyloid-mots-c-and-mortality-of-type-ii-diabetics-with-cad-17825https://curecurrent.com/trials/evaluation-of-the-effectiveness-of-m-dakbas-on-foot-care-17826https://curecurrent.com/trials/rosuvastatin-ezetimibe-vs-rosuvastatin-in-korean-patients-with-type-2-diabetes-mellitus-and-hypercholesterolemia-17827https://curecurrent.com/trials/study-for-the-effectiveness-of-intensive-therapy-aiming-at-a-remission-of-diabetic-nephropathy-17828https://curecurrent.com/trials/evaluation-of-cyp450-activities-in-diabetic-patients-vs-non-diabetic-subjects-17829https://curecurrent.com/trials/intravitreal-ranibizumab-or-aflibercept-after-bevacizumab-in-diabetic-macular-edema-17830https://curecurrent.com/trials/yh1-in-poorly-controlled-type-2-diabetes-17831https://curecurrent.com/trials/elastic-band-resistance-exercise-on-glycated-haemoglobin-and-muscle-strength-balance-and-physical-function-in-patients-w-17832https://curecurrent.com/trials/sport-as-therapy-a-6-months-lifestyle-intervention-for-patients-with-coronary-artery-disease-and-or-diabetes-17833https://curecurrent.com/trials/impact-of-diabetes-continuing-education-on-primary-health-care-physicians-knowledge-attitudes-and-practice-17834https://curecurrent.com/trials/study-to-evaluate-the-efficacy-and-safety-of-dwp16001-in-patients-with-type-2-diabetes-mellitus-17835https://curecurrent.com/trials/the-effect-of-iloprost-on-capillary-recruitment-and-insulin-sensitivity-in-type-2-diabetes-17836https://curecurrent.com/trials/a-study-of-all-cause-and-cardiovascular-mortality-in-type-2-diabetes-patients-using-basal-insulin-detemir-and-glargine-17837https://curecurrent.com/trials/statin-compliance-of-patients-with-non-insulin-dependent-diabetes-17838https://curecurrent.com/trials/efficacy-and-safety-of-insulin-lispro-biphasic-25-compared-to-humalog-mix-25-in-type-2-diabetes-mellitus-patients-17839https://curecurrent.com/trials/efficacy-and-safety-of-insulin-ringlar-compared-to-lantus-solostar-in-type-1-diabetes-mellitus-patients-17840https://curecurrent.com/trials/conversation-map-and-diabetes-in-pakistan-17841https://curecurrent.com/trials/impact-of-an-evidence-based-electronic-decision-support-system-on-diabetes-care-17842https://curecurrent.com/trials/possible-role-of-gingival-crevicular-fluid-levels-of-chemerin-and-fibroblast-growth-factor-21-as-biomarkers-of-periodont-17843https://curecurrent.com/trials/zoledronic-acid-or-methylprednisolone-for-active-charcot-s-neuroarthropathy-of-foot-in-patients-with-diabetes-mellitus-17844https://curecurrent.com/trials/diabetes-cohort-in-french-amazonia-17845https://curecurrent.com/trials/real-world-assessment-of-clinical-outcome-changes-including-month-of-ramadan-for-dapagliflozin-in-management-of-type-ii-17846https://curecurrent.com/trials/glucophage-immediate-release-gir-china-bioequivalence-study-17847https://curecurrent.com/trials/impact-of-changes-in-muscle-secretome-in-the-remission-of-type-2-diabetes-mellitus-induced-by-bariatric-surgery-17848https://curecurrent.com/trials/the-songdance-study-stress-ongoing-self-monitoring-and-diabetes-nerve-stimulation-and-cognitive-empowerment-17849https://curecurrent.com/trials/association-of-cystatin-c-and-bone-mineral-density-in-diabetic-patients-17850https://curecurrent.com/trials/the-cardiovascular-diabetes-ethanol-cascade-trial-17851https://curecurrent.com/trials/a-digital-therapy-for-diabetes-prevention-among-overweight-adults-in-terengganu-malaysia-17852https://curecurrent.com/trials/effects-of-combining-cocoa-and-soy-in-type-2-diabetes-17853https://curecurrent.com/trials/value-based-emotion-focused-educational-programme-to-reduce-diabetes-related-distress-17854https://curecurrent.com/trials/artificial-pancreas-in-pediatric-patients-pedarpan-17855https://curecurrent.com/trials/loss-to-follow-up-in-pdr-patients-17856https://curecurrent.com/trials/qingdao-insulin-pump-follow-up-program-17857https://curecurrent.com/trials/meal-time-administration-of-exenatide-for-glycaemic-control-in-type-1-diabetic-cases-17858https://curecurrent.com/trials/an-observational-study-of-alogliptin-benzoate-in-participants-with-diabetes-mellitus-type-2-17859https://curecurrent.com/trials/predictive-markers-of-glitazone-efficacy-in-diabetic-patients-pilot-study-17860https://curecurrent.com/trials/effects-of-liraglutide-on-the-cognitive-function-in-patients-with-type-2-diabetes-mellitus-17861https://curecurrent.com/trials/remodelling-in-diabetic-cardiomapathy-gender-response-to-pde5i-inhibitors-17862https://curecurrent.com/trials/does-dapagliflozin-regress-left-ventricular-hypertrophy-in-patients-with-type-2-diabetes-17863https://curecurrent.com/trials/feasibility-of-rehit-in-ndh-patients-17864https://curecurrent.com/trials/efficacy-and-safety-of-insulin-rinsulin-nph-compared-to-humulin-nph-in-type-2-diabetes-mellitus-patients-17865https://curecurrent.com/trials/effect-of-linagliptin-metformin-vs-metformin-alone-in-patients-with-prediabetes-17866https://curecurrent.com/trials/the-effects-of-neprilysin-on-glucagon-like-peptide-1-17867https://curecurrent.com/trials/hyperglycemic-response-and-steroid-administration-after-surgery-dexglysurgery-17868https://curecurrent.com/trials/long-term-retinal-changes-after-topical-citicoline-administration-in-patients-with-mild-signs-of-diabetic-retinopathy-in-17869https://curecurrent.com/trials/effect-of-food-on-the-pharmacokinetics-of-nnc0123-0000-0338-in-a-tablet-formulation-in-healthy-subjects-17870https://curecurrent.com/trials/secular-trends-in-the-prevalence-of-diabetes-in-india-17871https://curecurrent.com/trials/transporters-for-organic-cations-and-glycemic-control-in-patients-with-neuropathic-pain-17872https://curecurrent.com/trials/clinical-characteristics-and-practice-patterns-of-type-2-diabetes-mellitus-patients-treated-with-oads-in-japan-analysis-17873https://curecurrent.com/trials/the-effect-of-topical-doxycycline-gel-on-hba1c-in-patients-with-type-2-diabetes-mellitus-dm-17874https://curecurrent.com/trials/alcohol-consumption-and-type-2-diabetes-mellitus-risk-in-nonalcoholic-fatty-liver-disease-17875https://curecurrent.com/trials/effect-of-continuous-vs-intermittent-aerobic-exercise-on-glycemic-control-in-a-barbadian-population-with-type-2-diabetes-17876https://curecurrent.com/trials/c-peptide-concentrations-in-type-2-diabetes-treated-with-insulin-is-it-time-to-revise-the-treatment-of-type-2-diabetes-17877https://curecurrent.com/trials/evaluation-of-white-sweet-potato-tube-feeding-formula-on-type-2-diabetic-residents-in-long-term-care-institutions-17878https://curecurrent.com/trials/the-efficacy-of-glucerna-sr-in-chinese-drug-na-ve-subjects-with-type-2-diabetes-17879https://curecurrent.com/trials/pinto-beans-and-glycemic-control-in-adults-with-type-2-diabetes-17880https://curecurrent.com/trials/get-a-grip-lifestyle-management-programme-17881https://curecurrent.com/trials/dietary-impacts-on-glucose-lowering-effects-of-sitagliptin-in-type-2-diabetes-17882https://curecurrent.com/trials/nitrite-effects-on-cardiac-muscle-in-cabg-17883https://curecurrent.com/trials/insulin-degludec-and-symptomatic-nocturnal-hypoglycaemia-17884https://curecurrent.com/trials/the-effect-of-combination-of-vitamin-a-vitamin-e-sodium-hyaluronate-0-15-eye-drop-compared-with-sodium-hyaluronate-0-1-e-17885https://curecurrent.com/trials/the-effect-of-gip-and-glp-1-on-insulin-and-glucagon-secretion-in-patients-with-hnf1a-diabetes-treated-with-or-without-su-17886https://curecurrent.com/trials/anti-vegf-therapy-versus-dexamethasone-implant-for-dme-17887https://curecurrent.com/trials/effect-of-an-l-carnitine-containing-peritoneal-dialysis-pd-solution-on-insulin-sensitivity-in-diabetic-patients-on-conti-17888https://curecurrent.com/trials/mindful-self-compassion-to-assist-emerging-adults-with-diabetes-transition-to-adulthood-17889https://curecurrent.com/trials/a-study-to-assess-the-effect-of-a-3-month-folate-supplementation-on-systemic-homocysteine-plasma-concentration-and-ocula-17890https://curecurrent.com/trials/researching-an-effect-of-glp-1-agonist-on-liver-steatosis-realist-17891https://curecurrent.com/trials/investigation-of-otelixizumab-in-new-onset-autoimmune-type-1-diabetes-mellitus-patients-17892https://curecurrent.com/trials/a-study-of-ly2605541-and-glargine-in-participants-with-type-1-diabetes-17893https://curecurrent.com/trials/a-feasibility-study-of-the-regenercell-autologous-cell-harvesting-device-for-diabetic-foot-ulcers-17894https://curecurrent.com/trials/metformin-continuation-versus-interruption-following-coronary-angiography-a-pilot-randomized-controlled-trial-17895https://curecurrent.com/trials/efficacy-of-androgen-substitution-for-hypogonadism-in-men-with-type-2-diabetes-mellitus-17896https://curecurrent.com/trials/reducing-with-metformin-vascular-adverse-lesions-in-type-1-diabetes-removal-17897https://curecurrent.com/trials/a-trial-investigating-the-effect-of-probenecid-and-ciclosporin-on-the-concentrations-of-snac-in-healthy-subjects-17898https://curecurrent.com/trials/a-study-of-ly2881835-in-healthy-people-and-people-with-diabetes-17899https://curecurrent.com/trials/a-trial-comparing-the-pharmacokinetic-properties-of-fast-acting-insulin-aspart-between-children-adolescents-and-adults-w-17900https://curecurrent.com/trials/prediction-and-prevention-of-asymptomatic-cardiovascular-insult-in-type-1-diabetic-children-comparative-effectiveness-of-17901https://curecurrent.com/trials/apico-coronal-position-of-the-implant-in-edentulous-diabetics-with-implant-retained-overdentures-17902https://curecurrent.com/trials/effect-of-rotating-magnetic-therapy-on-blood-glucose-spectrum-of-type-2-diabetic-patients-with-glargine-therapy-17903https://curecurrent.com/trials/macular-thickness-measurements-using-retinal-thickness-oct-17904https://curecurrent.com/trials/micropulsed-laser-in-association-with-anti-vegf-for-the-treatment-of-macular-edema-in-diabetic-patients-lamed-17905https://curecurrent.com/trials/determinants-of-type-2-diabetes-risk-in-middle-aged-black-south-african-men-and-women-17906https://curecurrent.com/trials/comparing-the-renal-effect-of-dipeptidyl-peptidase-4-inhibitors-and-sulfonylureas-17907https://curecurrent.com/trials/development-and-testing-of-a-new-generation-of-diabetic-footwear-17908https://curecurrent.com/trials/vortioxetine-vs-sertraline-in-mexicans-17909https://curecurrent.com/trials/efficacy-and-safety-of-semaglutide-once-weekly-versus-sitagliptin-once-daily-as-add-on-to-metformin-and-or-tzd-in-subjec-17910https://curecurrent.com/trials/traditional-chinese-medicine-in-individualized-treatment-of-patients-with-diabetes-symptoms-17911https://curecurrent.com/trials/the-blood-glucose-control-in-patients-with-type-2-diabetes-treated-with-glargine-17912https://curecurrent.com/trials/comparing-efficacy-and-safety-of-thrice-daily-versus-twice-daily-novomix-30-biphasic-insulin-aspart-30-in-subjects-with-17913https://curecurrent.com/trials/effect-of-fgm-on-glucose-control-in-diabetic-patients-17914https://curecurrent.com/trials/effects-of-replacing-lantus-with-basalin-on-the-glycemic-variation-in-patients-with-type-2-diabetes-mellitus-17915https://curecurrent.com/trials/ultrasound-guided-intervention-and-hand-tenosynovitis-in-patients-with-diabetes-mellitus-17916https://curecurrent.com/trials/serum-ferritin-and-hepicidin-concentration-in-chronic-periodontitis-patients-with-t2dm-17917https://curecurrent.com/trials/closed-loop-control-of-glucose-levels-artificial-pancreas-for-24-hours-in-adults-with-type-2-diabetes-under-intensive-in-17918https://curecurrent.com/trials/characteristics-of-patients-with-type-2-diabetes-mellitus-cvd-rndr-17919https://curecurrent.com/trials/comprehensive-care-in-type-1-diabetes-and-associated-outcomes-17920https://curecurrent.com/trials/effect-of-13-week-treatment-with-vildagliptin-as-add-on-therapy-to-improve-glucose-variability-in-type-ii-diabetes-17921https://curecurrent.com/trials/an-extension-study-of-peak-trial-17922https://curecurrent.com/trials/copeptin-and-the-s-100b-protein-in-stroke-17923https://curecurrent.com/trials/progressive-vs-non-progressive-water-based-aerobic-training-on-type-2-diabetes-control-a-randomized-clinical-trial-17924https://curecurrent.com/trials/effects-of-structured-simplified-short-term-intensive-insulin-therapy-on-long-term-glycemic-remission-17925https://curecurrent.com/trials/china-protection-trial-of-glucose-metabolism-by-pitavastatin-in-patients-with-prediabetes-and-hypertension-17926https://curecurrent.com/trials/a-study-of-ly2922470-in-healthy-participants-and-participants-with-diabetes-17927https://curecurrent.com/trials/the-effect-of-exercise-on-gut-microbiota-in-type-2-diabetic-patients-17928https://curecurrent.com/trials/assessment-with-ccta-and-mri-in-asymptomatic-patients-with-type-2-diabetes-for-detection-of-unrecognized-myocardial-scar-17929https://curecurrent.com/trials/evaluation-of-early-retinal-nerve-injury-in-type-2-diabetes-patients-without-diabetic-retinopathy-17930https://curecurrent.com/trials/bloodstream-absorption-of-avastin-and-lucentis-after-injection-into-the-eye-17931https://curecurrent.com/trials/clinical-trial-of-efficacy-and-safety-of-subetta-in-the-combined-treatment-of-patients-with-type-ii-diabetes-mellitus-17932https://curecurrent.com/trials/a-12-24-weeks-open-multi-centre-phase-iv-study-on-safety-and-efficacy-of-2mg-exenatide-once-weekly-bydureon-in-t2dm-pati-17933https://curecurrent.com/trials/an-investigational-drug-study-in-patients-with-type-2-diabetes-mellitus-mk0431-023-17934https://curecurrent.com/trials/relationship-between-diabetes-and-cognitive-impairment-based-on-olfactory-function-assessment-and-functional-mri-17935https://curecurrent.com/trials/evaluation-of-woulgan-in-diabetic-foot-ulcer-17936https://curecurrent.com/trials/investigating-the-pharmacokinetic-properties-of-nn1250-in-healthy-chinese-subjects-17937https://curecurrent.com/trials/clinical-trial-of-efficacy-and-safety-of-subetta-in-the-combined-treatment-of-patients-with-type-i-diabetes-mellitus-17938https://curecurrent.com/trials/seasonal-trends-of-respiratory-morbidity-in-diabetic-patients-17939https://curecurrent.com/trials/teneligliptin-and-atorvastatin-ddi-study-17940https://curecurrent.com/trials/the-effect-of-floorball-on-health-and-performance-in-subjects-with-lifestyle-diseases-17941https://curecurrent.com/trials/human-solute-carrier-family-5-member-2-slc5a2-deficiency-and-the-glucagon-incretin-axis-17942https://curecurrent.com/trials/web-smartphone-based-lifestyle-coaching-program-in-pregnant-women-with-gestational-diabetes-17943https://curecurrent.com/trials/effects-of-docosahexaenoic-acid-dha-on-cardiovascular-disease-on-diabetic-patients-17944https://curecurrent.com/trials/cystic-fibrosis-related-diabetes-screening-17945https://curecurrent.com/trials/flash-glucose-measurement-in-patients-on-total-parenteral-nutrition-17946https://curecurrent.com/trials/pancreatic-duodenal-homeobox-factor-1-pdx-1-and-neurogenin-3-ngn-3-in-gestational-diabetes-17947https://curecurrent.com/trials/study-to-assess-the-effects-and-safety-of-zgn-1061-in-overweight-and-obese-participants-with-type-2-diabetes-17948https://curecurrent.com/trials/a-multicenter-randomized-double-blind-non-inferiority-trial-to-evaluate-the-efficacy-and-safety-of-entelon-17949https://curecurrent.com/trials/involvement-of-community-pharmacists-in-complex-care-plans-for-diabetic-patients-a-pilot-study-17950https://curecurrent.com/trials/a-trial-investigating-the-pharmacokinetic-and-pharmacodynamic-properties-of-faster-acting-insulin-aspart-in-subjects-wit-17951https://curecurrent.com/trials/effects-of-chewing-gum-on-glycaemic-control-in-women-with-gestational-diabetes-17952https://curecurrent.com/trials/effect-of-vitamin-d3-supplementation-on-cardiometabolic-risk-17953https://curecurrent.com/trials/a-phase-2-12-week-double-blind-efficacy-and-safety-of-gx-g6-in-patients-with-uncontrolled-type-2-diabetes-mellitus-17954https://curecurrent.com/trials/effects-of-liraglutid-dapagliflozin-and-acarbose-on-the-cognitive-function-olfactory-function-and-odor-induced-brain-act-17955https://curecurrent.com/trials/effect-of-tahneek-on-hypoglycemia-in-newborn-infants-17956https://curecurrent.com/trials/glp-1-receptor-agonists-and-real-world-evidence-17957https://curecurrent.com/trials/alzer-and-diamel-to-prevent-severe-diabetes-macular-edema-17958https://curecurrent.com/trials/efficacy-of-black-seed-oil-in-patients-with-type-2-diabetes-mellitus-17959https://curecurrent.com/trials/peer-support-in-diabetes-management-insulin-peer-support-17960https://curecurrent.com/trials/a-multi-center-study-on-the-artificial-intelligence-enabled-diabetic-retinopathy-screening-based-on-fundus-images-17961https://curecurrent.com/trials/the-effect-of-continuous-glucose-monitoring-on-glycemic-control-and-pregnancy-outcomes-in-gestational-diabetes-mellitus-17962https://curecurrent.com/trials/hyperbaric-oxygenation-in-diabetic-ulcer-17963https://curecurrent.com/trials/the-effects-of-hemodialysis-on-serum-sclerostin-levels-17964https://curecurrent.com/trials/cerebrovascular-effects-of-the-use-of-alpha-stat-or-ph-stat-management-of-cardiopulmonary-bypass-17965https://curecurrent.com/trials/pulmonary-effects-of-diabetes-mellitus-17966https://curecurrent.com/trials/the-influence-of-water-and-salt-intake-on-copeptin-levels-during-moderate-alcohol-consumption-17967https://curecurrent.com/trials/mindfulness-program-for-older-diabetes-17968https://curecurrent.com/trials/comarum-palustre-in-knee-osteoarthritis-and-diabetes-17969https://curecurrent.com/trials/influence-of-prior-walking-on-postprandial-metabolism-and-endothelial-function-17970https://curecurrent.com/trials/the-effect-of-biscuit-containing-kothala-himbutu-on-blood-glucose-in-patients-with-diabetes-a-randomized-control-study-17971https://curecurrent.com/trials/co-ingestion-of-rice-bran-soymilk-or-plain-soymilk-with-white-bread-effects-on-the-glycaemic-and-insulinaemic-response-17972https://curecurrent.com/trials/the-effect-of-pharmaceutical-grade-l-glutamine-endari-on-glycemic-control-in-patients-with-diabetes-mellitus-type-ii-17973https://curecurrent.com/trials/topical-tranexamic-acid-plus-perivascular-vasopressin-at-the-time-of-abdominal-myomectomy-17974https://curecurrent.com/trials/effects-of-glutamine-on-glp-1-and-insulin-secretion-in-man-17975https://curecurrent.com/trials/food-modification-to-alter-glycaemia-and-insulinaemia-17976https://curecurrent.com/trials/prevalence-of-peripheral-neuropathy-and-its-impact-on-activities-of-daily-living-in-patients-with-type-2-diabetes-17977https://curecurrent.com/trials/the-norwegian-pancreas-transplantation-ptx-study-17978https://curecurrent.com/trials/bm-mncs-and-uc-mscs-infusion-for-type-2-diabetes-mellitus-patients-17979https://curecurrent.com/trials/evaluation-of-the-efficacy-of-omk2-in-recovering-corneal-neural-damage-in-patients-with-diabetes-17980https://curecurrent.com/trials/influence-of-diabetic-neuropathy-on-activation-of-brown-adipose-tissue-17981https://curecurrent.com/trials/impact-of-meal-order-on-postprandial-cardiometabolic-risk-markers-17982https://curecurrent.com/trials/pilot-study-of-an-intervention-involving-cognitive-training-and-tdcs-in-morbidly-obese-subjects-17983https://curecurrent.com/trials/mindfulness-for-adolescents-with-type-1-diabetes-17984https://curecurrent.com/trials/health-and-exercise-response-in-children-with-chronic-and-auto-immune-pathologies-17985https://curecurrent.com/trials/effects-of-multidisciplinary-intensive-targeted-care-in-improving-diabetes-outcomes-a-pilot-study-in-singapore-17986https://curecurrent.com/trials/safety-and-efficacy-study-of-adjuvanted-prophylactic-hepatitis-b-vaccine-17987https://curecurrent.com/trials/intergenerational-mhealth-diabetes-program-opportunities-program-in-taiwan-17988https://curecurrent.com/trials/coronary-artery-disease-progression-in-patients-with-acute-coronary-syndromes-and-diabetes-mellitus-17989https://curecurrent.com/trials/empagliflozin-in-post-transplantation-diabetes-mellitus-17990https://curecurrent.com/trials/the-acute-effect-of-physical-activity-on-blood-glucose-in-pregnant-women-17991https://curecurrent.com/trials/progression-from-impaired-fasting-glucose-to-diabetes-mellitus-among-chinese-17992https://curecurrent.com/trials/clinical-profile-and-laboratory-finding-of-dfu-from-tertiary-hospitals-in-bali-17993https://curecurrent.com/trials/an-innovative-virtually-supervised-exercise-for-dialysis-patients-17994https://curecurrent.com/trials/diabetes-prevention-immune-tolerance-17995https://curecurrent.com/trials/diffusion-tensor-imaging-of-median-nerve-in-diabetic-peripheral-neuropathy-17996https://curecurrent.com/trials/investigating-the-effectiveness-of-tresiba-insulin-degludec-after-switching-basal-insulin-in-a-population-with-type-1-or-17997https://curecurrent.com/trials/investigating-the-structural-and-functional-changes-to-the-retina-following-prp-in-diabetic-retinopathy-patients-17998https://curecurrent.com/trials/the-effect-of-intra-abdominal-pressure-17999https://curecurrent.com/trials/performance-of-the-dexcom-g6-continuous-glucose-monitoring-cgm-system-in-pregnant-women-with-diabetes-mellitus-18000